| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 7.46e-07 | 8 | 206 | 4 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 2.20e-06 | 10 | 206 | 4 | GO:0140999 | |
| GeneOntologyMolecularFunction | double-stranded RNA adenosine deaminase activity | 2.12e-05 | 6 | 206 | 3 | GO:0003726 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 4.68e-05 | 20 | 206 | 4 | GO:0042800 | |
| GeneOntologyMolecularFunction | tRNA-specific adenosine deaminase activity | 5.83e-05 | 8 | 206 | 3 | GO:0008251 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | PSD TBC1D2 ARHGEF17 TBC1D22A RIN2 RGL2 ARAP1 IQSEC3 ARHGAP23 GIT1 ARHGAP17 ARHGEF10L TBC1D10A ARHGEF10 KNDC1 RAPGEFL1 | 7.78e-05 | 507 | 206 | 16 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | PSD TBC1D2 ARHGEF17 TBC1D22A RIN2 RGL2 ARAP1 IQSEC3 ARHGAP23 GIT1 ARHGAP17 ARHGEF10L TBC1D10A ARHGEF10 KNDC1 RAPGEFL1 | 7.78e-05 | 507 | 206 | 16 | GO:0030695 |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 8.72e-05 | 44 | 206 | 5 | GO:0140938 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | HIC1 ZNF219 SCRT1 ESRRA DACH1 SAMD7 NFATC3 HSF4 TBX2 TCF3 ZBTB4 ARX | 1.29e-04 | 320 | 206 | 12 | GO:0001227 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | PSD ARHGEF17 RIN2 RGL2 IQSEC3 ARHGEF10L TBC1D10A ARHGEF10 KNDC1 RAPGEFL1 | 1.49e-04 | 231 | 206 | 10 | GO:0005085 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | HIC1 ZNF219 SCRT1 ESRRA DACH1 SAMD7 NFATC3 HSF4 TBX2 TCF3 ZBTB4 ARX | 1.53e-04 | 326 | 206 | 12 | GO:0001217 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | ESRRA SOX18 MESP1 SIX4 JUND NFATC3 HSF4 FOXC1 FOXD1 FOXN1 TCF3 ZNF628 ARX KLF15 POU2F2 RELB | 2.42e-04 | 560 | 206 | 16 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | ESRRA SOX18 MESP1 SIX4 JUND NFATC3 HSF4 FOXC1 FOXD1 FOXN1 TCF3 ZNF628 ARX KLF15 POU2F2 RELB | 2.73e-04 | 566 | 206 | 16 | GO:0001216 |
| GeneOntologyMolecularFunction | adenosine deaminase activity | 2.87e-04 | 13 | 206 | 3 | GO:0004000 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | HIC1 ZNF219 ZBTB38 SCRT1 SALL3 ESRRA DACH1 SOX18 SAMD7 MESP1 SIX4 CIC JUND NFATC3 HES7 HSF4 FOXC1 FOXD1 TBX2 FOXN1 TCF3 ZNF628 ZBTB4 ARX KLF15 POU2F2 RELB ZSCAN10 CUX1 | 2.95e-04 | 1412 | 206 | 29 | GO:0000981 |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 6.85e-04 | 68 | 206 | 5 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 7.32e-04 | 69 | 206 | 5 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 8.34e-04 | 71 | 206 | 5 | GO:0042054 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | PAG1 PPRC1 ZFPM1 BCL3 BCOR GAB2 RETREG3 JUND MAVS TCERG1 MAMSTR HAX1 PARP15 ANKRD13D MAPK8IP1 AMFR ARID3A NIBAN2 PARP14 SHANK3 GAS2L1 SHARPIN CUX1 RAB11FIP3 | 9.18e-04 | 1160 | 206 | 24 | GO:0030674 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF219 ZBTB38 SCRT1 SALL3 ESRRA DACH1 SOX18 MESP1 SIX4 JUND NFATC3 HES7 HSF4 FOXC1 FOXD1 TBX2 TCF3 ZNF628 ZBTB4 ARX KLF15 POU2F2 RELB ZSCAN10 CUX1 | 1.08e-03 | 1244 | 206 | 25 | GO:0000978 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF219 ZBTB38 SCRT1 SALL3 ESRRA DACH1 SOX18 MESP1 SIX4 BCOR CIC JUND NFATC3 EHMT2 HES7 HSF4 FOXC1 FOXD1 TBX2 TCF3 ZNF628 ZBTB4 ARX KLF15 POU2F2 RELB ZSCAN10 CUX1 | 1.09e-03 | 1459 | 206 | 28 | GO:0000977 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF219 ZBTB38 SCRT1 SALL3 ESRRA DACH1 SOX18 MESP1 SIX4 JUND NFATC3 HES7 HSF4 FOXC1 FOXD1 TBX2 TCF3 ZNF628 ZBTB4 ARX KLF15 POU2F2 RELB ZSCAN10 CUX1 | 1.45e-03 | 1271 | 206 | 25 | GO:0000987 |
| GeneOntologyMolecularFunction | histamine receptor activity | 1.55e-03 | 6 | 206 | 2 | GO:0004969 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 2.23e-03 | 129 | 206 | 6 | GO:0035591 | |
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D2 TBC1D22A RIN2 ARAP1 ARHGAP23 GIT1 ARHGAP17 ARHGEF10L TBC1D10A | 2.52e-03 | 279 | 206 | 9 | GO:0005096 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | HIC1 ZNF219 ZBTB38 SCRT1 ESRRA DACH1 SOX18 SAMD7 ZFPM1 MESP1 BCL3 SIX4 BCOR CIC JUND ZNF469 TCERG1 NFATC3 EHMT2 NFKBIE HES7 HSF4 FOXC1 FOXD1 TBX2 PARP15 TCF3 SET ZBTB4 ARX RELB NIBAN2 PARP14 ZSCAN10 CUX1 | 5.41e-07 | 1399 | 208 | 35 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | HIC1 ZNF219 ZBTB38 SCRT1 ESRRA DACH1 SOX18 SAMD7 ZFPM1 MESP1 BCL3 SIX4 BCOR CIC JUND ZNF469 TCERG1 NFATC3 EHMT2 NFKBIE HES7 HSF4 FOXC1 FOXD1 TBX2 PARP15 TCF3 SET ZBTB4 ARX RELB NIBAN2 PARP14 ZSCAN10 CUX1 | 6.83e-07 | 1413 | 208 | 35 | GO:1902679 |
| GeneOntologyBiologicalProcess | adenosine to inosine editing | 3.43e-05 | 7 | 208 | 3 | GO:0006382 | |
| GeneOntologyBiologicalProcess | nephron epithelium development | 4.75e-05 | 128 | 208 | 8 | GO:0072009 | |
| GeneOntologyCellularComponent | EMILIN complex | 9.76e-05 | 2 | 207 | 2 | GO:1990971 | |
| Domain | Post-SET_dom | 5.86e-07 | 16 | 204 | 5 | IPR003616 | |
| Domain | PostSET | 5.86e-07 | 16 | 204 | 5 | SM00508 | |
| Domain | POST_SET | 5.86e-07 | 16 | 204 | 5 | PS50868 | |
| Domain | PH_dom-like | PSD TBC1D2 ARHGEF17 SHC3 GAB2 PLEKHH3 PHLDB1 PHLPP1 ARAP1 MAPK8IP1 IQSEC3 ARHGAP23 TNS2 NIBAN2 CDC42BPB ARHGEF10L ARHGEF10 TNS1 | 1.08e-06 | 426 | 204 | 18 | IPR011993 |
| Domain | - | PSD TBC1D2 ARHGEF17 SHC3 GAB2 PLEKHH3 PHLDB1 PHLPP1 ARAP1 MAPK8IP1 IQSEC3 ARHGAP23 TNS2 NIBAN2 CDC42BPB ARHGEF10L TNS1 | 1.48e-06 | 391 | 204 | 17 | 2.30.29.30 |
| Domain | ANK | BCL3 ANKRD63 BCOR SOWAHC EHMT2 NFKBIE GIT1 ESPNL SHANK3 SOWAHA ANKRD33B PPP1R12C | 2.13e-05 | 251 | 204 | 12 | SM00248 |
| Domain | ANK_REPEAT | BCL3 ANKRD63 BCOR SOWAHC EHMT2 NFKBIE GIT1 ESPNL SHANK3 SOWAHA ANKRD33B PPP1R12C | 2.31e-05 | 253 | 204 | 12 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | BCL3 ANKRD63 BCOR SOWAHC EHMT2 NFKBIE GIT1 ESPNL SHANK3 SOWAHA ANKRD33B PPP1R12C | 2.40e-05 | 254 | 204 | 12 | IPR020683 |
| Domain | ANK_REP_REGION | BCL3 ANKRD63 BCOR SOWAHC EHMT2 NFKBIE GIT1 ESPNL SHANK3 SOWAHA ANKRD33B PPP1R12C | 2.40e-05 | 254 | 204 | 12 | PS50297 |
| Domain | ADEAMc | 2.51e-05 | 6 | 204 | 3 | SM00552 | |
| Domain | A_deamin | 2.51e-05 | 6 | 204 | 3 | PF02137 | |
| Domain | A_DEAMIN_EDITASE | 2.51e-05 | 6 | 204 | 3 | PS50141 | |
| Domain | A_deamin | 2.51e-05 | 6 | 204 | 3 | IPR002466 | |
| Domain | Ank_2 | BCL3 ANKRD63 BCOR SOWAHC EHMT2 NFKBIE GIT1 ESPNL SHANK3 ANKRD33B PPP1R12C | 2.54e-05 | 215 | 204 | 11 | PF12796 |
| Domain | Ankyrin_rpt | BCL3 ANKRD63 BCOR SOWAHC EHMT2 NFKBIE GIT1 ESPNL SHANK3 SOWAHA ANKRD33B PPP1R12C | 3.25e-05 | 262 | 204 | 12 | IPR002110 |
| Domain | RA | 4.24e-05 | 36 | 204 | 5 | PF00788 | |
| Domain | RA_dom | 7.14e-05 | 40 | 204 | 5 | IPR000159 | |
| Domain | SET | 8.06e-05 | 41 | 204 | 5 | PF00856 | |
| Domain | - | BCL3 ANKRD63 BCOR SOWAHC EHMT2 NFKBIE GIT1 ESPNL SHANK3 ANKRD33B PPP1R12C | 9.26e-05 | 248 | 204 | 11 | 1.25.40.20 |
| Domain | N-SET | 1.19e-04 | 2 | 204 | 2 | PF11764 | |
| Domain | MeTrfase_trithorax | 1.19e-04 | 2 | 204 | 2 | IPR016569 | |
| Domain | N-SET | 1.19e-04 | 2 | 204 | 2 | SM01291 | |
| Domain | Histamine_H3_rcpt | 1.19e-04 | 2 | 204 | 2 | IPR003980 | |
| Domain | COMPASS_Set1_N-SET | 1.19e-04 | 2 | 204 | 2 | IPR024657 | |
| Domain | SET | 1.41e-04 | 46 | 204 | 5 | SM00317 | |
| Domain | SET_dom | 2.10e-04 | 50 | 204 | 5 | IPR001214 | |
| Domain | SET | 2.10e-04 | 50 | 204 | 5 | PS50280 | |
| Domain | Ank | BCL3 BCOR SOWAHC EHMT2 NFKBIE GIT1 ESPNL SOWAHA ANKRD33B PPP1R12C | 2.11e-04 | 228 | 204 | 10 | PF00023 |
| Domain | PH | PSD TBC1D2 GAB2 PLEKHH3 PHLDB1 PHLPP1 ARAP1 IQSEC3 ARHGAP23 NIBAN2 CDC42BPB | 2.51e-04 | 278 | 204 | 11 | SM00233 |
| Domain | PH_DOMAIN | PSD TBC1D2 GAB2 PLEKHH3 PHLDB1 PHLPP1 ARAP1 IQSEC3 ARHGAP23 NIBAN2 CDC42BPB | 2.59e-04 | 279 | 204 | 11 | PS50003 |
| Domain | PH_domain | PSD TBC1D2 GAB2 PLEKHH3 PHLDB1 PHLPP1 ARAP1 IQSEC3 ARHGAP23 NIBAN2 CDC42BPB | 2.67e-04 | 280 | 204 | 11 | IPR001849 |
| Domain | AT_hook | 6.47e-04 | 16 | 204 | 3 | PF02178 | |
| Domain | RA | 6.88e-04 | 37 | 204 | 4 | PS50200 | |
| Domain | Myotonic_dystrophy_kinase_coil | 7.02e-04 | 4 | 204 | 2 | IPR014930 | |
| Domain | Tensin_PTB | 7.02e-04 | 4 | 204 | 2 | IPR033929 | |
| Domain | Myotonic_dystrophy_kinase_coil | 7.02e-04 | 4 | 204 | 2 | PD011252 | |
| Domain | DMPK_coil | 7.02e-04 | 4 | 204 | 2 | PF08826 | |
| Domain | PDZ | 9.21e-04 | 141 | 204 | 7 | PF00595 | |
| Domain | PTB | 9.28e-04 | 40 | 204 | 4 | SM00462 | |
| Domain | PTB/PI_dom | 1.02e-03 | 41 | 204 | 4 | IPR006020 | |
| Domain | DSRM | 1.09e-03 | 19 | 204 | 3 | SM00358 | |
| Domain | FYrich_C | 1.16e-03 | 5 | 204 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.16e-03 | 5 | 204 | 2 | IPR003888 | |
| Domain | FYRC | 1.16e-03 | 5 | 204 | 2 | SM00542 | |
| Domain | FYRN | 1.16e-03 | 5 | 204 | 2 | SM00541 | |
| Domain | FYRN | 1.16e-03 | 5 | 204 | 2 | PF05964 | |
| Domain | FYRC | 1.16e-03 | 5 | 204 | 2 | PF05965 | |
| Domain | FYRC | 1.16e-03 | 5 | 204 | 2 | PS51543 | |
| Domain | FYRN | 1.16e-03 | 5 | 204 | 2 | PS51542 | |
| Domain | PDZ | 1.22e-03 | 148 | 204 | 7 | SM00228 | |
| Domain | dsrm | 1.28e-03 | 20 | 204 | 3 | PF00035 | |
| Domain | - | 1.32e-03 | 150 | 204 | 7 | 2.30.42.10 | |
| Domain | PDZ | 1.37e-03 | 151 | 204 | 7 | PS50106 | |
| Domain | PDZ | 1.43e-03 | 152 | 204 | 7 | IPR001478 | |
| Domain | DS_RBD | 1.48e-03 | 21 | 204 | 3 | PS50137 | |
| Domain | LDLRA_1 | 1.85e-03 | 48 | 204 | 4 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 1.99e-03 | 49 | 204 | 4 | IPR002172 | |
| Domain | LDLa | 1.99e-03 | 49 | 204 | 4 | SM00192 | |
| Domain | LDLRA_2 | 1.99e-03 | 49 | 204 | 4 | PS50068 | |
| Domain | Ski_Sno | 2.40e-03 | 7 | 204 | 2 | PF02437 | |
| Domain | - | 2.40e-03 | 7 | 204 | 2 | 3.10.260.20 | |
| Domain | Transform_Ski | 2.40e-03 | 7 | 204 | 2 | IPR003380 | |
| Domain | RASGEF | 2.77e-03 | 26 | 204 | 3 | PS00720 | |
| Domain | AT_hook | 3.10e-03 | 27 | 204 | 3 | SM00384 | |
| Domain | - | 3.10e-03 | 27 | 204 | 3 | 3.30.160.20 | |
| Domain | AT_hook_DNA-bd_motif | 3.10e-03 | 27 | 204 | 3 | IPR017956 | |
| Domain | PTEN_C2 | 3.18e-03 | 8 | 204 | 2 | PF10409 | |
| Domain | PTB | 3.18e-03 | 8 | 204 | 2 | IPR013625 | |
| Domain | PTEN_C2 | 3.18e-03 | 8 | 204 | 2 | SM01326 | |
| Domain | PTB | 3.18e-03 | 8 | 204 | 2 | PF08416 | |
| Domain | C2_TENSIN | 3.18e-03 | 8 | 204 | 2 | PS51182 | |
| Domain | Tensin_lipid_phosphatase_dom | 3.18e-03 | 8 | 204 | 2 | IPR029023 | |
| Domain | Tensin_C2-dom | 3.18e-03 | 8 | 204 | 2 | IPR014020 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 4.40e-05 | 65 | 140 | 6 | M39374 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 7.15e-05 | 44 | 140 | 5 | MM15527 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 8.89e-05 | 46 | 140 | 5 | MM14933 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1A SETD1B KMT2B PPRC1 ZFPM1 MBD6 RNF43 CIC PLEKHH3 PRR12 JUND PHLDB1 SSH1 ZFP36L2 LRRC56 TP53I13 RGL2 ZNF687 ARAP1 ANKRD13D SEMA3F ARID3A ZNF628 SZT2 ZBTB4 MYOM3 LAMA5 ARHGAP17 ADGRL1 RELB STK32C CDC42BPB FBXO46 RASSF7 ARHGEF10L C6orf132 MICALL1 GAS2L1 INTS5 LRP3 TNKS1BP1 ANKRD33B CEP170B RAB11FIP3 | 2.28e-23 | 1105 | 212 | 44 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ARHGEF17 ZYX CIC GAB2 PHLDB1 TCERG1 ZFP36L2 NFATC3 MAP3K9 KMT2A NHS GNAS RGL2 WNK4 TTC28 GIT1 ARHGAP17 STK32C RASSF7 C6orf132 MICALL1 MAP7D1 ARHGEF10 FAM53B TNKS1BP1 SRRM2 CEP170B PPP1R12C | 6.42e-13 | 861 | 212 | 28 | 36931259 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | HIC1 ZBTB38 ESRRA SOX18 ZFPM1 MESP1 SIX4 ZC3H3 CIC JUND ZFP36L2 NFATC3 HES7 KMT2A HSF4 FOXC1 TBX2 FOXN1 TCF3 ZBTB4 ARX KLF15 POU2F2 RELB ZNF385A | 3.98e-10 | 908 | 212 | 25 | 19274049 |
| Pubmed | IL16 ZNF219 PSD ESRRA BCOR SOWAHC ZC3H3 RNF43 ZNF469 EHMT2 HAX1 ZNF687 FOXC1 TBX2 SET TTC28 ARHGAP23 CECR2 TAF1C MAP7D1 SOWAHA CAVIN1 TIGD5 LZTS2 SRRM2 CEP170B | 5.68e-09 | 1116 | 212 | 26 | 31753913 | |
| Pubmed | 6.68e-09 | 5 | 212 | 4 | 25561738 | ||
| Pubmed | SETD1A BCOR NACAD KLHL9 MRC2 ZNF687 ARAP1 SZT2 CECR2 LAMA5 ARHGEF10L MICALL1 INTS5 FAM53B TNKS1BP1 LZTS2 MINDY1 | 3.25e-08 | 529 | 212 | 17 | 14621295 | |
| Pubmed | 4.45e-08 | 83 | 212 | 8 | 28794006 | ||
| Pubmed | HIC1 ZNF219 ESRRA SOX18 SIX4 RNF43 ZYX CIC JUND KLHL9 NFKBIE KMT2A ZNF687 TCF3 ARID3A POU2F2 RELB TIGD5 CUX1 | 8.64e-08 | 709 | 212 | 19 | 22988430 | |
| Pubmed | 9.22e-08 | 8 | 212 | 4 | 22266653 | ||
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 9.22e-08 | 8 | 212 | 4 | 23130995 | |
| Pubmed | 1.65e-07 | 9 | 212 | 4 | 22665483 | ||
| Pubmed | KMT2B SIX4 BCOR CIC PRR12 TCERG1 ZFP36L2 EHMT2 KMT2A ZNF687 TBX2 SET TAF1C LAMA5 ZNF385A CDC42BPB PLPP6 C6orf132 INTS5 MAP7D1 TBC1D10A PTCD1 CRACDL LZTS2 CROCC CEP170B PPP1R12C | 5.09e-07 | 1497 | 212 | 27 | 31527615 | |
| Pubmed | 6.39e-07 | 12 | 212 | 4 | 27563068 | ||
| Pubmed | SUMOylation of DDX39A Alters Binding and Export of Antiviral Transcripts to Control Innate Immunity. | ZNF219 ZFPM1 GAB2 AMER2 MAVS FAM229A NHS BAIAP3 TBX2 IQSEC3 NECAB2 ARHGAP23 POU2F2 RELB FBXO46 PLPP6 GUCY1A2 MARVELD2 SYTL1 DNAAF1 | 9.77e-07 | 915 | 212 | 20 | 32393512 |
| Pubmed | KMT2B ESRRA PRR12 JUND NOP9 TCERG1 EHMT2 KMT2A HAX1 ZNF687 FOXC1 SET TAF1C LAMA5 NIBAN2 INTS5 CAVIN1 SRRM2 CUX1 | 1.26e-06 | 847 | 212 | 19 | 35850772 | |
| Pubmed | 2.21e-06 | 5 | 212 | 3 | 9271224 | ||
| Pubmed | 2.31e-06 | 16 | 212 | 4 | 23870121 | ||
| Pubmed | 3.65e-06 | 104 | 212 | 7 | 9205841 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KMT2B ESRRA TBC1D2 ZFPM1 BCOR ZYX CIC JUND SSH1 KMT2A ZNF687 GIT1 NIBAN2 MICALL1 INTS5 TNKS1BP1 SRRM2 | 6.16e-06 | 774 | 212 | 17 | 15302935 |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | HIC1 SCRT1 ESRRA SOX18 SIX4 JUND NFATC3 HES7 HSF4 TBX2 ARX KLF15 POU2F2 CUX1 | 7.23e-06 | 544 | 212 | 14 | 28473536 |
| Pubmed | IL16 ARHGEF17 PHLDB1 KCND3 KMT2A HAX1 MAPK8IP1 IQSEC3 ARHGAP23 GIT1 ADGRL1 CDC42BPB SHANK3 MAL2 GAS2L1 MAP7D1 GUCY1A2 CRACDL KNDC1 TNKS1BP1 CROCC TNS1 CEP170B PPP1R12C | 7.84e-06 | 1431 | 212 | 24 | 37142655 | |
| Pubmed | SETD1B PPRC1 ARHGEF17 PHLDB1 BAIAP3 IQSEC3 TTC28 ADGRL1 MAP7D1 CROCC SRRM2 CEP170B | 8.61e-06 | 407 | 212 | 12 | 12693553 | |
| Pubmed | 8.90e-06 | 119 | 212 | 7 | 23508102 | ||
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 9.01e-06 | 22 | 212 | 4 | 26886794 | |
| Pubmed | Systematic screening for skin, hair, and nail abnormalities in a large-scale knockout mouse program. | 1.10e-05 | 171 | 212 | 8 | 28700664 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | PAG1 ZYX MAVS NFKBIE NHS ARHGAP23 NIBAN2 C6orf132 MICALL1 TBC1D10A TNKS1BP1 MARVELD2 LZTS2 SNX1 | 1.10e-05 | 565 | 212 | 14 | 25468996 |
| Pubmed | Interaction network of human early embryonic transcription factors. | SETD1A KMT2B SCAND1 SIX4 MBD6 BCOR PRR12 EHMT2 KMT2A TBX2 ARID3A | 1.17e-05 | 351 | 212 | 11 | 38297188 |
| Pubmed | 1.36e-05 | 50 | 212 | 5 | 37974198 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | PAG1 SCARF2 PARD6G PHLDB1 GNAS NIBAN2 CDC42BPB MICALL1 TBC1D10A CAVIN1 LZTS2 | 2.26e-05 | 377 | 212 | 11 | 38117590 |
| Pubmed | SETD1A KMT2B DACH1 SIX4 MBD6 BCOR CIC PRR12 JUND TCERG1 NFATC3 EHMT2 NFKBIE KMT2A ZNF687 FOXC1 TCF3 ARID3A KLF15 RELB MAP7D1 SRRM2 CUX1 | 2.34e-05 | 1429 | 212 | 23 | 35140242 | |
| Pubmed | Molecular regulation of H3K4 trimethylation by Wdr82, a component of human Set1/COMPASS. | 2.60e-05 | 10 | 212 | 3 | 18838538 | |
| Pubmed | 2.60e-05 | 57 | 212 | 5 | 18022353 | ||
| Pubmed | SIX4 BCOR ZYX CIC SSH1 PHLPP1 NHS HAX1 FOXC1 DUSP8 TNS2 NIBAN2 CDC42BPB CSPG5 MARVELD2 LZTS2 SRRM2 TNS1 PPP1R12C | 2.60e-05 | 1049 | 212 | 19 | 27880917 | |
| Pubmed | SETD1A KMT2B DACH1 BCOR ZYX TCERG1 NFKBIE KMT2A TTC28 TNKS1BP1 LZTS2 SNX1 CUX1 | 3.65e-05 | 549 | 212 | 13 | 38280479 | |
| Pubmed | Multiple-interactions among EMILIN1 and EMILIN2 N- and C-terminal domains. | 3.70e-05 | 2 | 212 | 2 | 25445627 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 12185581 | ||
| Pubmed | Tensin1 and a previously undocumented family member, tensin2, positively regulate cell migration. | 3.70e-05 | 2 | 212 | 2 | 11792844 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 29550807 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 22569042 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 35850307 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 12584029 | ||
| Pubmed | Evaluation of Lama5 as a candidate for the mouse ragged (Ra) mutation. | 3.70e-05 | 2 | 212 | 2 | 9735344 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 34350769 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 26026087 | ||
| Pubmed | Conservation of structure and function between human and murine IL-16. | 3.70e-05 | 2 | 212 | 2 | 9637508 | |
| Pubmed | EMILIN2 regulates platelet activation, thrombus formation, and clot retraction. | 3.70e-05 | 2 | 212 | 2 | 25658937 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 22566882 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 24550110 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 24285545 | ||
| Pubmed | In Vivo and In Vitro Characterization of the RNA Binding Capacity of SETD1A (KMT2F). | 3.70e-05 | 2 | 212 | 2 | 38003223 | |
| Pubmed | The mitochondrial localization of RelB and NFATx in immature T cells. | 3.70e-05 | 2 | 212 | 2 | 18463795 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 12193717 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 27796741 | ||
| Pubmed | ADAD2 functions in spermiogenesis and piRNA biogenesis in mice. | 3.70e-05 | 2 | 212 | 2 | 36698249 | |
| Pubmed | Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression. | 3.70e-05 | 2 | 212 | 2 | 13678786 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 29862528 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 12727841 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 1729694 | ||
| Pubmed | Role of IL-6 and CD23 in the resistance to growth arrest and apoptosis in LCL41 B lymphoma cells. | 3.70e-05 | 2 | 212 | 2 | 16009564 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 19477016 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 29184034 | ||
| Pubmed | Proteolytic control of Interleukin-11 and Interleukin-6 biology. | 3.70e-05 | 2 | 212 | 2 | 28630024 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 25749274 | ||
| Pubmed | KMT2A and KMT2B Mediate Memory Function by Affecting Distinct Genomic Regions. | 3.70e-05 | 2 | 212 | 2 | 28723559 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 8011597 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 11278945 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 15121272 | ||
| Pubmed | HMGB1 interacts with many apparently unrelated proteins by recognizing short amino acid sequences. | 4.22e-05 | 32 | 212 | 4 | 11748221 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZNF219 KMT2B SIX4 BCOR CIC PRR12 JUND NOP9 TCERG1 EHMT2 HES7 KMT2A ZNF687 FOXC1 TCF3 TAF1C INTS5 MAP7D1 TIGD5 SRRM2 CUX1 | 4.80e-05 | 1294 | 212 | 21 | 30804502 |
| Pubmed | ZNF219 SALL3 KMT2B ESRRA SCAND1 SAMD7 KMT2A TBX2 SEMA3F AMFR TCF3 SET WNT2B DUSP8 ZNF385A FAM53B CROCC ANKRD33B | 5.00e-05 | 1006 | 212 | 18 | 15226823 | |
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 5.45e-05 | 108 | 212 | 6 | 19531213 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | SETD1A SETD1B KMT2B SKIDA1 MBD6 BCOR SOWAHC EHMT2 KMT2A GIT1 FBXO46 SOWAHA | 5.83e-05 | 495 | 212 | 12 | 27705803 |
| Pubmed | LMTK3 AMER2 AMFR IQSEC3 GIT1 ADGRL1 PLPP6 TNKS1BP1 SRRM2 CEP170B | 5.91e-05 | 347 | 212 | 10 | 17114649 | |
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | ZNF219 ESRRA LMTK3 HES7 LRRC56 NHS DMPK HSF4 SET SZT2 TNS2 NIBAN2 FBXO46 ARHGEF10L ARHGEF10 TNKS1BP1 CAVIN1 RAB11FIP3 | 6.03e-05 | 1021 | 212 | 18 | 26760575 |
| Pubmed | 6.11e-05 | 13 | 212 | 3 | 24619213 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SETD1B ESRRA BCOR CIC TCERG1 NFATC3 GNAS TTC28 GIT1 ARHGAP17 TNKS1BP1 LZTS2 CEP170B | 7.31e-05 | 588 | 212 | 13 | 38580884 |
| Pubmed | Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. | 7.74e-05 | 14 | 212 | 3 | 28263302 | |
| Pubmed | 7.75e-05 | 225 | 212 | 8 | 12168954 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | DACH1 SIX4 CIC JUND NOP9 TCERG1 FOXC1 FOXD1 TBX2 FOXN1 ARID3A POU2F2 RELB MAP7D1 CUX1 GAA | 8.10e-05 | 857 | 212 | 16 | 25609649 |
| Pubmed | ZNF219 APC2 LMTK3 BCOR SSH1 NFATC3 EHMT2 MAPK8IP1 IQSEC3 GIT1 HCN4 CDC42BPB SHANK3 MAP7D1 TNS1 CEP170B CUX1 | 9.55e-05 | 963 | 212 | 17 | 28671696 | |
| Pubmed | 9.63e-05 | 15 | 212 | 3 | 35907431 | ||
| Pubmed | 9.88e-05 | 233 | 212 | 8 | 37704626 | ||
| Pubmed | A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. | 1.08e-04 | 302 | 212 | 9 | 30561431 | |
| Pubmed | 1.11e-04 | 3 | 212 | 2 | 31754344 | ||
| Pubmed | 1.11e-04 | 3 | 212 | 2 | 12819039 | ||
| Pubmed | 1.11e-04 | 3 | 212 | 2 | 30898894 | ||
| Pubmed | 1.11e-04 | 3 | 212 | 2 | 7536685 | ||
| Pubmed | 1.11e-04 | 3 | 212 | 2 | 17578910 | ||
| Pubmed | 1.11e-04 | 3 | 212 | 2 | 23697798 | ||
| Pubmed | 1.11e-04 | 3 | 212 | 2 | 34852217 | ||
| Pubmed | 1.11e-04 | 3 | 212 | 2 | 36791667 | ||
| Pubmed | 1.11e-04 | 3 | 212 | 2 | 29483644 | ||
| Pubmed | PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer. | 1.11e-04 | 3 | 212 | 2 | 31399573 | |
| Pubmed | NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells. | 1.11e-04 | 3 | 212 | 2 | 14707079 | |
| Pubmed | 1.11e-04 | 3 | 212 | 2 | 19690169 | ||
| Pubmed | 1.11e-04 | 3 | 212 | 2 | 29973688 | ||
| Pubmed | 1.11e-04 | 3 | 212 | 2 | 26478434 | ||
| Pubmed | EMILINs interact with anthrax protective antigen and inhibit toxin action in vitro. | 1.11e-04 | 3 | 212 | 2 | 17988845 | |
| Pubmed | Foxc1 reinforces quiescence in self-renewing hair follicle stem cells. | 1.11e-04 | 3 | 212 | 2 | 26912704 | |
| Pubmed | Induction of ureter branching as a response to Wnt-2b signaling during early kidney organogenesis. | 1.11e-04 | 3 | 212 | 2 | 11507767 | |
| Interaction | TOP3B interactions | SETD1A SETD1B KMT2B PPRC1 ZFPM1 MBD6 RNF43 CIC PLEKHH3 PRR12 JUND PHLDB1 SSH1 ZFP36L2 LRRC56 TP53I13 GNAS RGL2 ZNF687 ARAP1 ANKRD13D SEMA3F ARID3A ZNF628 SZT2 ZBTB4 MYOM3 LAMA5 ARHGAP17 ADGRL1 RELB STK32C CDC42BPB FBXO46 RASSF7 ARHGEF10L C6orf132 MICALL1 GAS2L1 INTS5 LRP3 TNKS1BP1 ANKRD33B CEP170B RAB11FIP3 | 2.11e-11 | 1470 | 206 | 45 | int:TOP3B |
| Interaction | NFIX interactions | SETD1A KMT2B DACH1 SIX4 BCOR CIC PRR12 EHMT2 KMT2A FOXC1 FOXN1 ARID3A CUX1 | 6.45e-07 | 227 | 206 | 13 | int:NFIX |
| Interaction | FEV interactions | SETD1A KMT2B DACH1 SIX4 BCOR CIC PRR12 EHMT2 KMT2A FOXC1 ARID3A CUX1 | 1.26e-06 | 203 | 206 | 12 | int:FEV |
| Interaction | EN1 interactions | 1.75e-05 | 110 | 206 | 8 | int:EN1 | |
| Interaction | YWHAH interactions | PARD6G ARHGEF17 CIC GAB2 PHLDB1 SSH1 TCERG1 ZFP36L2 NFATC3 MAP3K9 KMT2A NHS RGL2 TTC28 GIT1 KLF15 ARHGAP17 TNS2 RASSF7 C6orf132 MICALL1 MAP7D1 FAM53B TNKS1BP1 SRRM2 CEP170B PPP1R12C | 2.28e-05 | 1102 | 206 | 27 | int:YWHAH |
| Interaction | TBXT interactions | 2.57e-05 | 116 | 206 | 8 | int:TBXT | |
| Interaction | YWHAG interactions | ARHGEF17 CIC GAB2 PHLDB1 TTBK1 SSH1 TCERG1 ZFP36L2 NFATC3 MAP3K9 KMT2A NHS GNAS RGL2 TTC28 ARHGAP23 GIT1 ARHGAP17 TNS2 RASSF7 SHANK3 C6orf132 MICALL1 MAP7D1 FAM53B LZTS2 SRRM2 CEP170B PPP1R12C | 2.93e-05 | 1248 | 206 | 29 | int:YWHAG |
| Interaction | FOXL1 interactions | 3.52e-05 | 196 | 206 | 10 | int:FOXL1 | |
| Interaction | YWHAB interactions | ARHGEF17 RNF43 ZYX CIC GAB2 PHLDB1 SSH1 ZFP36L2 NFATC3 TBC1D22A MAP3K9 KMT2A NHS RGL2 TTC28 ARHGAP23 TNS2 SHANK3 C6orf132 MICALL1 MAP7D1 FAM53B SRRM2 CEP170B PPP1R12C | 4.25e-05 | 1014 | 206 | 25 | int:YWHAB |
| Interaction | CTDSP2 interactions | 4.44e-05 | 63 | 206 | 6 | int:CTDSP2 | |
| Interaction | NFIC interactions | 6.29e-05 | 210 | 206 | 10 | int:NFIC | |
| Interaction | MYB interactions | 6.84e-05 | 133 | 206 | 8 | int:MYB | |
| Interaction | TLX1 interactions | 8.16e-05 | 175 | 206 | 9 | int:TLX1 | |
| Interaction | RAC1 interactions | PARD6G SOWAHC MAVS MRC2 NHS GNAS DMPK RGL2 FMNL1 ARAP1 SET ARHGAP23 GIT1 ARHGAP17 ADGRL1 RELB NIBAN2 CDC42BPB SHANK3 MICALL1 LRP10 ARHGEF10 CAVIN1 MARVELD2 LZTS2 | 9.04e-05 | 1063 | 206 | 25 | int:RAC1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q24 | 4.31e-05 | 136 | 212 | 6 | chr16q24 | |
| Cytoband | 11p15.5 | 2.30e-04 | 118 | 212 | 5 | 11p15.5 | |
| Cytoband | 22q13.3 | 3.14e-04 | 6 | 212 | 2 | 22q13.3 | |
| Cytoband | 6p21.1 | 5.31e-04 | 80 | 212 | 4 | 6p21.1 | |
| Cytoband | 19p13.3 | 8.62e-04 | 237 | 212 | 6 | 19p13.3 | |
| Cytoband | 16p13.3 | 1.00e-03 | 244 | 212 | 6 | 16p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | IL11 KMT2B BCL3 LMTK3 CIC PRR12 MAMSTR DMPK ZNF628 POU2F2 RELB FBXO46 LRP3 PPP1R12C | 1.40e-03 | 1192 | 212 | 14 | chr19q13 |
| GeneFamily | Ankyrin repeat domain containing | BCL3 ANKRD63 BCOR SOWAHC EHMT2 NFKBIE ARAP1 ANKRD13D GIT1 ESPNL SHANK3 SOWAHA ANKRD33B PPP1R12C | 5.94e-09 | 242 | 140 | 14 | 403 |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 6.02e-06 | 34 | 140 | 5 | 487 | |
| GeneFamily | Adenosine deaminases acting on RNA | 2.47e-05 | 8 | 140 | 3 | 1303 | |
| GeneFamily | PDZ domain containing | 1.83e-04 | 152 | 140 | 7 | 1220 | |
| GeneFamily | C2 tensin-type domain containing|PTEN protein phosphatases|Phosphoinositide phosphatases | 5.86e-04 | 5 | 140 | 2 | 902 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.13e-03 | 206 | 140 | 7 | 682 | |
| GeneFamily | EMI domain containing | 1.22e-03 | 7 | 140 | 2 | 540 | |
| GeneFamily | Interleukin 6 cytokine family | 1.22e-03 | 7 | 140 | 2 | 1264 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 1.62e-03 | 8 | 140 | 2 | 837 | |
| GeneFamily | Synaptotagmin like tandem C2 proteins | 2.57e-03 | 10 | 140 | 2 | 822 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 3.64e-03 | 40 | 140 | 3 | 321 | |
| GeneFamily | Zinc fingers CXXC-type | 3.73e-03 | 12 | 140 | 2 | 136 | |
| GeneFamily | Low density lipoprotein receptors | 4.39e-03 | 13 | 140 | 2 | 634 | |
| GeneFamily | Forkhead boxes | 4.47e-03 | 43 | 140 | 3 | 508 | |
| GeneFamily | Endogenous ligands|Interleukins | 4.47e-03 | 43 | 140 | 3 | 601 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 7.50e-03 | 17 | 140 | 2 | 684 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | SETD1A PPRC1 CIC EHMT2 HSF4 ANKRD13D TCF3 SZT2 TAF1C ARHGAP17 FBXO46 RASSF7 MICALL1 SRRM2 PPP1R12C CAPN15 | 1.75e-08 | 338 | 211 | 16 | M17094 |
| Coexpression | PEREZ_TP53_TARGETS | HIC1 INAFM2 APC2 EMILIN2 BCOR ARHGEF17 RETREG3 SPATA2L KCNQ1 ASPSCR1 GNAS BAIAP3 ARAP1 FOXC1 DOC2B DOCK8-AS1 ARHGAP23 ARX ZNF385A C6orf132 LRP10 CRACDL KNDC1 FAM53B SNORC CROCC TNS1 MINDY1 CEP170B GAA | 3.74e-08 | 1201 | 211 | 30 | M4391 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | HIC1 SCRT1 SALL3 EMILIN2 SOX18 ANKRD63 SIX4 ARHGEF17 ZFP36L2 ADAMTS17 GNAS WNK4 FOXC1 FOXD1 TBX2 SEMA3F HCN4 ARX PARP14 RASSF7 GIPC3 MAL2 SOWAHA CAVIN1 ANKRD33B HRH3 | 5.99e-07 | 1074 | 211 | 26 | M1941 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | SETD1B TBC1D2 BCL3 LMTK3 MBD6 ZC3H3 ZYX JUND ZFP36L2 TP53I13 ASPSCR1 TAF1C NIBAN2 HEXD MAP7D1 SRRM2 SNX1 CUX1 | 4.23e-06 | 634 | 211 | 18 | M40866 |
| Coexpression | GSE12366_NAIVE_VS_MEMORY_BCELL_UP | FCER2 NFATC3 RGL2 MAPK8IP1 PARP14 GAS2L1 ARHGEF10 FAM53B IL6 TREML2 | 4.39e-06 | 195 | 211 | 10 | M3178 |
| Coexpression | TABULA_MURIS_SENIS_HEART_VENTRICULAR_MYOCYTE_AGEING | 6.00e-06 | 120 | 211 | 8 | MM3710 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | IL11 PAG1 HIC1 ZBTB38 ARHGEF17 ZYX ZNF469 PHLDB1 SSH1 MRC2 NHS TBX2 ARHGAP23 GUCY1A2 TNKS1BP1 CAVIN1 TNS1 IL6 | 1.12e-05 | 681 | 211 | 18 | M39175 |
| Coexpression | KIM_WT1_TARGETS_UP | 1.12e-05 | 217 | 211 | 10 | M9128 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | IL11 HIC1 RTL5 DACH1 ZFPM1 MESP1 ADARB2 SLITRK1 PHLDB1 AMER2 ADRB3 KCND3 ANXA2R HES7 ADAMTS17 KCNQ1 C1QTNF5 HSF4 FOXC1 TBX2 HCN4 DUSP8 SOWAHA RAB11FIP3 | 1.22e-05 | 1115 | 211 | 24 | M10371 |
| Coexpression | CRX_NRL_DN.V1_UP | 1.86e-05 | 140 | 211 | 8 | M2796 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP | 3.59e-05 | 199 | 211 | 9 | M7420 | |
| Coexpression | GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 3.74e-05 | 200 | 211 | 9 | M309 | |
| Coexpression | GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_DN | 3.74e-05 | 200 | 211 | 9 | M8643 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | PARD6G SOX18 RETREG3 PHLPP1 TTC28 ARHGAP23 NIBAN2 PARP14 TAMALIN | 3.74e-05 | 200 | 211 | 9 | M7518 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | TBC1D2 BCL3 LMTK3 MBD6 ZC3H3 ZYX GAB2 ZFP36L2 TP53I13 ASPSCR1 TAF1C NIBAN2 HEXD MAP7D1 LRP10 PTCD1 SRRM2 SNX1 CUX1 PPP1R12C | 4.70e-05 | 905 | 211 | 20 | M40865 |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 7.54e-05 | 219 | 211 | 9 | MM3826 | |
| Coexpression | DESCARTES_MAIN_FETAL_CCL19_CCL21_POSITIVE_CELLS | 9.18e-05 | 278 | 211 | 10 | M40127 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 | IL11 SCRT1 SOX18 MESP1 ANKRD63 KCNQ1 ALK IQSEC3 C6orf132 MAL2 HRH3 | 1.20e-04 | 345 | 211 | 11 | M2009 |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 | IL11 SCRT1 SOX18 MESP1 ANKRD63 KCNQ1 ALK IQSEC3 C6orf132 MAL2 HRH3 | 1.26e-04 | 347 | 211 | 11 | MM860 |
| Coexpression | GILMORE_CORE_NFKB_PATHWAY | 1.39e-04 | 13 | 211 | 3 | M8804 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | HIC1 JUND SSH1 TCERG1 FOXC1 SEMA3F ARHGAP23 CDC42BPB SHANK3 CAVIN1 | 1.49e-04 | 295 | 211 | 10 | M39121 |
| Coexpression | PEREZ_TP63_TARGETS | PSD APC2 ZFPM1 BCOR ARHGEF17 AIPL1 DOC2B ARX ZNF385A SHANK3 RAB11FIP3 | 1.58e-04 | 356 | 211 | 11 | M10761 |
| Coexpression | LIM_MAMMARY_LUMINAL_PROGENITOR_DN | 1.75e-04 | 14 | 211 | 3 | M2576 | |
| Coexpression | LIM_MAMMARY_LUMINAL_PROGENITOR_DN | 1.75e-04 | 14 | 211 | 3 | MM961 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | HIC1 EMILIN2 MARCHF11 FMNL1 WNK4 ANKRD13D SEMA3F MAPK8IP1 NECAB2 WNT2B GIPC3 CEP170B RAPGEFL1 | 1.95e-04 | 493 | 211 | 13 | M1951 |
| Coexpression | GSE27859_MACROPHAGE_VS_DC_DN | 1.98e-04 | 196 | 211 | 8 | M8588 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | PSD RTL5 DACH1 NACAD BAIAP3 MAPK8IP1 GIT1 ARX ADGRL1 POU2F2 ARHGEF10L CAPN15 | 2.01e-04 | 429 | 211 | 12 | M45694 |
| Coexpression | PDGF_ERK_DN.V1_DN | 2.12e-04 | 149 | 211 | 7 | M2828 | |
| Coexpression | GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_UP | 2.12e-04 | 198 | 211 | 8 | M8336 | |
| Coexpression | GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP | 2.20e-04 | 199 | 211 | 8 | M9754 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN | 2.20e-04 | 199 | 211 | 8 | M5251 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_LUNG_DN | 2.20e-04 | 199 | 211 | 8 | M4350 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 2.27e-04 | 200 | 211 | 8 | M5851 | |
| Coexpression | GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN | 2.27e-04 | 200 | 211 | 8 | M9757 | |
| Coexpression | GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_UP | 2.27e-04 | 200 | 211 | 8 | M7437 | |
| Coexpression | GSE22935_WT_VS_MYD88_KO_MACROPHAGE_UP | 2.27e-04 | 200 | 211 | 8 | M7760 | |
| Coexpression | GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN | 2.27e-04 | 200 | 211 | 8 | M7992 | |
| Coexpression | GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_DN | 2.27e-04 | 200 | 211 | 8 | M6798 | |
| Coexpression | GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_UP | 2.27e-04 | 200 | 211 | 8 | M9169 | |
| Coexpression | FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS | ZNF219 RNF19B PARD6G KLHDC7A GNAS ARAP1 POU2F2 ZNF385A MICALL1 SYTL1 | 2.28e-04 | 311 | 211 | 10 | M61 |
| Coexpression | AIZARANI_LIVER_C29_MVECS_2 | 2.40e-04 | 313 | 211 | 10 | M39128 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | HIC1 EMILIN2 MARCHF11 FMNL1 WNK4 ANKRD13D SEMA3F MAPK8IP1 NECAB2 WNT2B GIPC3 CEP170B RAPGEFL1 | 2.42e-04 | 504 | 211 | 13 | MM830 |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5 | 2.45e-04 | 108 | 211 | 6 | M1281 | |
| Coexpression | PEREZ_TP53_AND_TP63_TARGETS | 2.87e-04 | 207 | 211 | 8 | M14566 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_DN | 2.91e-04 | 72 | 211 | 5 | M40882 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP | DACH1 BCOR SPATA2L RGL2 ANKRD13D ARID3A DUSP8 HEXD LRP3 SRRM2 RAB11FIP3 | 3.09e-04 | 385 | 211 | 11 | M2840 |
| CoexpressionAtlas | gudmap_RNAseq_p2_CD2APMEISWT_2500_K4 | PAG1 ZBTB38 SCARF2 RTL5 PARD6G ARHGEF17 SHC3 PLEKHH3 RETREG3 KCND3 NFKBIE C1QTNF5 FOXC1 ARHGAP23 ZBTB4 LAMA5 KLF15 TNS2 PARP14 ARHGEF10L GUCY1A2 TNKS1BP1 TNS1 | 1.01e-05 | 842 | 209 | 23 | gudmap_RNAseq_p2_CD2APMEISWT_2500_K4 |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | SCRT1 SIX4 LMTK3 ADARB2 KCND3 MAP3K9 MARCHF11 FMNL1 IQSEC3 SHANK3 HRH3 | 5.20e-10 | 167 | 212 | 11 | 9efb9511a211d0824bb97f82c1a5860c43d2138f |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | SCRT1 SIX4 LMTK3 ADARB2 KCND3 MAP3K9 MARCHF11 FMNL1 IQSEC3 SHANK3 HRH3 | 5.20e-10 | 167 | 212 | 11 | 904c613aac3f9919a432b110bb1dcc832b5aec0a |
| ToppCell | Mild_COVID-19-Myeloid-MoAM5|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | IL11 RTL5 SIX4 ADAMTS17 FOXC1 DUSP8 LAMA5 NIBAN2 TNKS1BP1 CAVIN1 ANKRD33B | 6.29e-10 | 170 | 212 | 11 | b2daf46ab5a49590ede8f75e4240bfe6e9d8b764 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | HIC1 TBC1D2 ARHGEF17 NACAD ZYX ZNF469 MRC2 NHS DOC2B ARHGAP23 ANKRD33B | 2.68e-09 | 195 | 212 | 11 | 5562665dd3beb70e2358aa32611a337bef5731c1 |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-1|TCGA-Uvea / Sample_Type by Project: Shred V9 | RTL5 ZFPM1 MAVS MAPK8IP1 ZNF628 ZNF414 GAS2L1 LRP3 CAVIN1 TNS1 | 8.58e-09 | 168 | 212 | 10 | b427746929bb40e3d1b5f1c40d302b792d6b32a5 |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.08e-09 | 169 | 212 | 10 | 78eb70dd916724e476eabccf18fb7fcec4210308 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | DACH1 PHLDB1 RIN2 PHLPP1 TBX2 SEMA3F WNT2B LAMA5 TAMALIN SHANK3 | 2.77e-08 | 190 | 212 | 10 | 0a351609a72fd638c84b2435782e312ee6a33aac |
| ToppCell | normal-na-Lymphocytic_B-B_atypical-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | SCARF2 PLEKHH3 SERINC4 PARP15 IQSEC3 TCF3 DUSP8 POU2F2 TIGD5 | 1.08e-07 | 166 | 212 | 9 | 30a180b67572c3f4fb3a291f271f855e1b20005e |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ARHGEF17 SHC3 PLEKHH3 KCND3 TBX2 IQSEC3 WNT2B GUCY1A2 TNKS1BP1 | 1.53e-07 | 173 | 212 | 9 | d78397e65e997ddb995111a810f0e2a4f67d0765 |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | PAG1 DACH1 ARHGEF17 ADARB2 MAMSTR TBX2 NECAB2 GUCY1A2 PPP1R12C | 1.53e-07 | 173 | 212 | 9 | fd6653d6be9ca6ac36798590694efe03cb758c67 |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ARHGEF17 SHC3 PLEKHH3 KCND3 TBX2 IQSEC3 WNT2B GUCY1A2 TNKS1BP1 | 1.53e-07 | 173 | 212 | 9 | 3c852ffe22f4a5b632463086b08c669310684e80 |
| ToppCell | Immune_cells-pro-B|World / Lineage and Cell class | 1.61e-07 | 174 | 212 | 9 | e173adbf5789dfa20f3cbc668efde5f0992ac219 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | IL11 PPP1R3G NACAD KLF15 EMILIN1 GIPC3 PTCD1 CAVIN1 PPP1R12C | 1.69e-07 | 175 | 212 | 9 | c6c0196875f3b5293083cda6718300806a801941 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | IL11 PPP1R3G NACAD KLF15 EMILIN1 GIPC3 PTCD1 CAVIN1 PPP1R12C | 1.69e-07 | 175 | 212 | 9 | 82c4d1edaa0d3b82d3ef4676d6f6516104a2656a |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | INAFM2 TCF3 CECR2 SMIM41 GIPC3 CRACDL FAM53B ANKRD33B CEP170B | 1.78e-07 | 176 | 212 | 9 | 29cda51a99100ddd2928cadc92da40f001d7e1f4 |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | INAFM2 TCF3 CECR2 SMIM41 GIPC3 CRACDL FAM53B ANKRD33B CEP170B | 1.78e-07 | 176 | 212 | 9 | 01774a86d7d92f31a056b753f9844f923038003e |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | JUND FCER2 FMNL1 PARP15 ARID3A POU2F2 PARP14 TAMALIN ANKRD33B | 2.25e-07 | 181 | 212 | 9 | d66838fca0429cad2079cd8d92a5cd33eb0d3522 |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-07 | 184 | 212 | 9 | 89ac32e374a4379e4a6c6ea7603b1378b77c147f | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.59e-07 | 184 | 212 | 9 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-07 | 184 | 212 | 9 | 4df6027fa635996c1eddb920f88a5265772df1cd | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.97e-07 | 187 | 212 | 9 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.10e-07 | 188 | 212 | 9 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.39e-07 | 190 | 212 | 9 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.39e-07 | 190 | 212 | 9 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.71e-07 | 192 | 212 | 9 | c3dda7c48732b0b8bde36de282d64192f5e9b98f | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-07 | 193 | 212 | 9 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | Mild/Remission-B_memory-0|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.04e-07 | 194 | 212 | 9 | 4866093b50cdf895f06b60684cc3aaa9769aa4dc | |
| ToppCell | droplet-Lung-30m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | DACH1 PARD6G SOX18 TBX2 SEMA3F DUSP8 TAMALIN CAVIN1 ANKRD33B | 4.04e-07 | 194 | 212 | 9 | cf7f232827945fbafd2c298c08a799ab916c2472 |
| ToppCell | Mild/Remission-B_memory-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.22e-07 | 195 | 212 | 9 | 3c51f005d8546c570752f5f0ce6b8ac242d3c54b | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.22e-07 | 195 | 212 | 9 | 023e3c97dd3696d74f002ff8da0c04d876c82aef | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ARHGEF17 LAMA5 RASSF7 C6orf132 MAL2 MARVELD2 SNORC CEP170B FAM83A | 4.41e-07 | 196 | 212 | 9 | 9554ac6eb5f381bcde3ba40c32aa3fc340974540 |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.01e-07 | 199 | 212 | 9 | 854628ce91068093c14bd4d45ba38c41469f3549 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.01e-07 | 199 | 212 | 9 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.22e-07 | 200 | 212 | 9 | cd3c638961144a2fc91c437a173cc37c7452fa74 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | JUND ZFP36L2 GNAS FMNL1 ANKRD13D POU2F2 ZNF385A PARP14 SRRM2 | 5.22e-07 | 200 | 212 | 9 | 62c25042086f1afd1102e0720e933c2e476468fd |
| ToppCell | distal-Endothelial-Capillary_Intermediate_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | DACH1 BCL3 PHLDB1 LAMA5 TAMALIN SHANK3 ARHGEF10 CRACDL CAVIN1 | 5.22e-07 | 200 | 212 | 9 | 43bc48413b100a06f8edd9acd812296788fcbf5b |
| ToppCell | distal-Endothelial-Capillary_Intermediate_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | DACH1 BCL3 PHLDB1 LAMA5 TAMALIN SHANK3 ARHGEF10 CRACDL CAVIN1 | 5.22e-07 | 200 | 212 | 9 | 4d6714d48738cdee7d535923f6dd2431e5304741 |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.09e-07 | 155 | 212 | 8 | a4f2fffa8d0de760c556c3f8f1c91804eedbfa68 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 1.42e-06 | 167 | 212 | 8 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.42e-06 | 167 | 212 | 8 | 9a84f45345c75f2c8ff38a04245aadee2a26a240 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 1.69e-06 | 171 | 212 | 8 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.19e-06 | 177 | 212 | 8 | 452ec2df36c6d656a7cdadc55be545ccdb146a29 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.29e-06 | 178 | 212 | 8 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 178 | 212 | 8 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 178 | 212 | 8 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-06 | 179 | 212 | 8 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 2.45e-06 | 126 | 212 | 7 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.59e-06 | 181 | 212 | 8 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Control / Disease condition and Cell class | 2.59e-06 | 181 | 212 | 8 | f3e1d8fe5cf1eba19e51c3680a55306cae687fe9 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.70e-06 | 182 | 212 | 8 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 183 | 212 | 8 | bf7f1cb55ed55981b8b355d5774055c96e658ff2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 183 | 212 | 8 | 9533db4db2c6ae78d7ca1682cf4efed12183396f | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.81e-06 | 183 | 212 | 8 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 183 | 212 | 8 | f55081068213cc1cdb2acad58ff10f6b48b44c72 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 184 | 212 | 8 | dc7f6ee4062856a02423fff8b1cce62d46a9355c | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 3.04e-06 | 185 | 212 | 8 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.04e-06 | 185 | 212 | 8 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-06 | 186 | 212 | 8 | 37860daeecd6d412bd3797f30496a56da667fbd1 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-06 | 186 | 212 | 8 | 60830822d3de3147816693404fd03392e04c2b8e | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-06 | 186 | 212 | 8 | baebeffdd426ce767190ddefc857cc78e6a58d36 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery|Adult / Lineage, Cell type, age group and donor | 3.17e-06 | 186 | 212 | 8 | 2d1c4ea2e401db89971582ee54618a8b0c81b8ac | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.30e-06 | 187 | 212 | 8 | 150023e6a50c9da461f2321074d2d5e96caafb06 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 3.30e-06 | 187 | 212 | 8 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 3.30e-06 | 187 | 212 | 8 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.43e-06 | 188 | 212 | 8 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Control / Disease state, Lineage and Cell class | 3.43e-06 | 188 | 212 | 8 | f5b7dbc89f992c13280d36a34935be83906b1bc0 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 3.57e-06 | 189 | 212 | 8 | c76d8af2e0aa4a83ee0c3439c894566fbf117dd3 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-06 | 189 | 212 | 8 | 3e8e30160a8d6f531ff743cb5918c9e79481f1bd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-06 | 189 | 212 | 8 | 851f8144aed5c7f80302911cd6b03f14bde7b56d | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-06 | 189 | 212 | 8 | 385ef7bbd76c8047aeecf6542377d4213b5da5db | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-06 | 189 | 212 | 8 | 32e6d6285b258831b965281224ff2aaeecdcb5f5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-06 | 190 | 212 | 8 | 1c5cf933ce71fed5638b9ef31eb81f6c2b6dadbc | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-06 | 190 | 212 | 8 | 1803b1e7c36285f9eaabc3c6e9a9752c5908db3d | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.86e-06 | 191 | 212 | 8 | c715bbdbbf1482aad45a50a16d5232fd35a9a0bb | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.86e-06 | 191 | 212 | 8 | 243d83cbfcc4996ad087ec6386e559e0b8662004 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-06 | 193 | 212 | 8 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-06 | 193 | 212 | 8 | 536b277d90070c4571c592a3c6323b4bf4819f67 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-06 | 193 | 212 | 8 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | Control-Fibroblasts-Vascular_smooth_muscle|Control / group, cell type (main and fine annotations) | 4.16e-06 | 193 | 212 | 8 | 60e44aac8be0430ad35e20eb98b1b700d76a0427 | |
| ToppCell | (6)_Endothelial-C_(Capillary_Aerocyte_)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.16e-06 | 193 | 212 | 8 | f7f2dc6aff02d096a282835094d26d12b3b73e61 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.16e-06 | 193 | 212 | 8 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-06 | 137 | 212 | 7 | b831d917f5073ccff158662adb281d34f023126a | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-06 | 137 | 212 | 7 | cf3e928d9a7a7349840bb87475a42a07f65b94f0 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-06 | 137 | 212 | 7 | 5d82d6c7eef4ec7a7fae60e37fb956488314987e | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.33e-06 | 194 | 212 | 8 | f15e81ff12525523c62d13105cf264ea72205e2e | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-06 | 194 | 212 | 8 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-06 | 194 | 212 | 8 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.49e-06 | 195 | 212 | 8 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.66e-06 | 196 | 212 | 8 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-06 | 196 | 212 | 8 | 22fcfb713f402ebbd43b2822f0fd919cdbfba6e4 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.84e-06 | 197 | 212 | 8 | 515a2d0ee2bd3fc0a5a0c315e2b0c752e6af7406 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.84e-06 | 197 | 212 | 8 | bfa04e5f4156a01df4217b1f59676edb0a7563e1 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.84e-06 | 197 | 212 | 8 | 4fccdc69ab4b966de6465f06677435e6f6e6abcd | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.84e-06 | 197 | 212 | 8 | e8e879b7634a29569061d3515d180784094a31e7 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.03e-06 | 198 | 212 | 8 | 002424b24dacac553e02d0f764a6e8a1e567b9df | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.22e-06 | 199 | 212 | 8 | 07bda4ac8ffdce1a865ebc99e46c2a27925ff7a8 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-06 | 199 | 212 | 8 | 14a7c4cf4bb3d43fd32ec9cc74f6625b225ffaa1 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.22e-06 | 199 | 212 | 8 | 53b6a661d381b1ed3ea96e61e8bd1750de7d9fda | |
| ToppCell | facs-Lung-18m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.22e-06 | 199 | 212 | 8 | c11e0044d3cc37f6bb26df033ad4448b419addfc | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Bronchial_vessel|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.22e-06 | 199 | 212 | 8 | 9c753043024871b1f1436fc39defac4da85e10cd | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | KMT2B PPRC1 BCL3 SPATA2L ZFP36L2 ARAP1 FOXC1 AMFR TCF3 DUSP8 ADGRL1 GAS2L1 ARHGEF10 RAB11FIP3 | 3.02e-09 | 191 | 210 | 14 | 1008_DN |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | KMT2B RNF19B ZYX CIC TBC1D22A TCF3 TAF1C RASSF7 GAS2L1 MAP7D1 SHARPIN SRRM2 GAA CAPN15 | 4.50e-09 | 197 | 210 | 14 | 1697_DN |
| Drug | Thyroxine (L) [51-48-9]; Down 200; 5.2uM; MCF7; HT_HG-U133A | RNF19B SCAND1 BCL3 TBC1D22A ARAP1 TBX2 TTC28 ADGRL1 SHARPIN LRP3 DNAAF1 SRRM2 MINDY1 CAPN15 | 5.12e-09 | 199 | 210 | 14 | 3249_DN |
| Drug | fullerene C60 | ZNF219 ZBTB38 PPRC1 APC2 SOX18 ZFPM1 MBD6 RNF43 SLITRK1 GAB2 JUND ZFP36L2 EHMT2 KCNQ1 MARCHF11 RGL2 FMNL1 WNK4 TBX2 DOC2B MAPK8IP1 FOXN1 UTS2R BCL2L10 KLF15 NIBAN2 CDC42BPB SHANK3 CSF2RB PWWP3A LZTS2 DNAAF1 TNS1 ANKRD33B IL6 PPP1R12C | 1.13e-07 | 1498 | 210 | 36 | ctd:C069837 |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | BCL3 SPATA2L JUND ZFP36L2 FOXC1 DUSP8 MICALL1 GAS2L1 ARHGEF10 DNAAF1 CAPN15 RAPGEFL1 | 2.01e-07 | 189 | 210 | 12 | 1651_DN |
| Drug | Naringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A | SETD1A KMT2B ESRRA CIC ZFP36L2 BAIAP3 TBX2 SZT2 TAF1C ADGRL1 SRRM2 CAPN15 | 2.82e-07 | 195 | 210 | 12 | 3278_UP |
| Drug | (d,l)-Tetrahydroberberine [522-97-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | IL11 RNF19B ZC3H3 ZYX PHLDB1 ZFP36L2 ARAP1 SZT2 RELB ARHGEF10 SHARPIN CAVIN1 | 2.98e-07 | 196 | 210 | 12 | 2818_UP |
| Drug | Domperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A | DACH1 JUND ZFP36L2 TBC1D22A KMT2A FMNL1 DUSP8 RASSF7 FAM53B TNS1 CEP170B CAPN15 | 2.98e-07 | 196 | 210 | 12 | 1301_DN |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | ESRRA DACH1 BCL3 SPATA2L ZFP36L2 ASPSCR1 TBX2 TCF3 RASSF7 GAS2L1 CSPG5 | 1.71e-06 | 191 | 210 | 11 | 998_DN |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HG-U133A | IL11 PPRC1 BCL3 CIC ZFP36L2 KMT2A BAIAP3 KLF15 RASSF7 TNS1 MINDY1 | 1.80e-06 | 192 | 210 | 11 | 611_DN |
| Drug | Prednisolone [50-24-8]; Up 200; 11uM; PC3; HT_HG-U133A | IL16 ZFP36L2 NFATC3 KCND3 TBC1D22A DMPK TBX2 ARHGEF10 FAM53B IL6 RAPGEFL1 | 1.80e-06 | 192 | 210 | 11 | 5101_UP |
| Drug | Nilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A | ARHGEF17 ZC3H3 ZFP36L2 BAIAP3 ARAP1 SEMA3F TCF3 TAF1C CAVIN1 SRRM2 RAB11FIP3 | 2.00e-06 | 194 | 210 | 11 | 5362_UP |
| Drug | Idoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | IL11 ZC3H3 PHLDB1 RIN2 SEMA3F GIT1 TAF1C RASSF7 SNX1 CAPN15 RAB11FIP3 | 2.00e-06 | 194 | 210 | 11 | 1480_DN |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | SETD1A RNF19B DACH1 ARHGEF17 ZC3H3 DMPK SEMA3F TCF3 ADGRL1 TNS2 RELB | 2.20e-06 | 196 | 210 | 11 | 2225_DN |
| Drug | Guaifenesin [93-14-1]; Up 200; 20.2uM; MCF7; HT_HG-U133A | SETD1A KMT2B JUND PHLDB1 SSH1 TBC1D22A ASPSCR1 TCF3 TAF1C RELB TNS1 | 2.32e-06 | 197 | 210 | 11 | 3431_UP |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | TBC1D2 ZFP36L2 NFATC3 TBC1D22A BAIAP3 ARAP1 ADGRL1 RELB MAP7D1 CAVIN1 GAA | 2.43e-06 | 198 | 210 | 11 | 6786_UP |
| Drug | Dioxybenzone [131-53-3]; Up 200; 16.4uM; HL60; HT_HG-U133A | IL16 ZNF219 MRC2 AIPL1 DMPK BAIAP3 ALK BCL2L10 TTC28 GUCY1A2 TNS1 | 2.55e-06 | 199 | 210 | 11 | 3101_UP |
| Drug | Methyldopa (L,-) [555-30-6]; Up 200; 19uM; PC3; HT_HG-U133A | IL11 RYK TBC1D22A DMPK ARAP1 SEMA3F TCF3 BCL2L10 TAF1C CSPG5 TNS1 | 2.68e-06 | 200 | 210 | 11 | 4677_UP |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | PPRC1 BCL3 SPATA2L ZFP36L2 ASPSCR1 FOXC1 RASSF7 GAS2L1 INTS5 RAPGEFL1 | 1.18e-05 | 191 | 210 | 10 | 1057_DN |
| Drug | troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | RNF19B BCOR ZFP36L2 NFATC3 ARAP1 TAF1C RELB FBXO46 SHARPIN MINDY1 | 1.30e-05 | 193 | 210 | 10 | 6949_UP |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | SETD1A DACH1 CIC JUND PHLDB1 SEMA3F GIT1 MAP7D1 PWWP3A SRRM2 | 1.30e-05 | 193 | 210 | 10 | 1667_DN |
| Drug | Zidovudine, AZT [30516-87-1]; Down 200; 15uM; PC3; HT_HG-U133A | ZYX PHLDB1 ZFP36L2 TBC1D22A TBX2 SEMA3F TNS2 TNS1 CAPN15 RAPGEFL1 | 1.30e-05 | 193 | 210 | 10 | 6733_DN |
| Drug | Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A | CIC ZFP36L2 NFATC3 ASPSCR1 SEMA3F TCF3 ADGRL1 SRRM2 GAA RAB11FIP3 | 1.36e-05 | 194 | 210 | 10 | 1707_DN |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | RNF19B ZYX JUND ZFP36L2 TBC1D22A ADGRL1 GAS2L1 CAPN15 RAPGEFL1 RAB11FIP3 | 1.36e-05 | 194 | 210 | 10 | 4246_DN |
| Drug | Dipyrone [5907-38-0]; Up 200; 12uM; PC3; HT_HG-U133A | 1.36e-05 | 194 | 210 | 10 | 4310_UP | |
| Drug | Florfenicol [73231-34-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | SPATA2L ZFP36L2 GIT1 DUSP8 ADGRL1 ARHGEF10 DNAAF1 TNS1 IL6 RAB11FIP3 | 1.42e-05 | 195 | 210 | 10 | 6701_DN |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | SETD1A ARHGEF17 PHLDB1 ASPSCR1 FOXC1 SEMA3F TCF3 ADGRL1 RASSF7 CAVIN1 | 1.42e-05 | 195 | 210 | 10 | 2223_DN |
| Drug | Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; HL60; HT_HG-U133A | JUND ZFP36L2 GNAS TAF1C RASSF7 INTS5 FAM53B TNS1 CUX1 CAPN15 | 1.42e-05 | 195 | 210 | 10 | 1274_DN |
| Drug | Berberine chloride [633-65-8]; Up 200; 10.8uM; MCF7; HT_HG-U133A | RNF19B TBC1D2 ARHGEF17 ZFP36L2 ARAP1 BCL2L10 SZT2 ADGRL1 POU2F2 CAPN15 | 1.42e-05 | 195 | 210 | 10 | 2770_UP |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A | IL11 ESRRA ARHGEF17 CIC PHLPP1 SEMA3F TAF1C ADGRL1 CSPG5 DNAAF1 | 1.42e-05 | 195 | 210 | 10 | 1501_DN |
| Drug | Fusidic acid sodium salt [751-94-0]; Down 200; 7.4uM; HL60; HT_HG-U133A | ESRRA CIC ZFP36L2 FMNL1 DUSP8 ARHGEF10L SHARPIN FAM53B CEP170B CAPN15 | 1.42e-05 | 195 | 210 | 10 | 1293_DN |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 1uM; PC3; HT_HG-U133A | SETD1A ESRRA JUND TCF3 GIT1 TAF1C GAS2L1 SNX1 CAPN15 RAB11FIP3 | 1.42e-05 | 195 | 210 | 10 | 4333_DN |
| Drug | Cyanocobalamin [68-19-9]; Up 200; 3uM; MCF7; HT_HG-U133A | SETD1B CIC JUND ZFP36L2 TBC1D22A RIN2 PHLPP1 DMPK TCF3 SRRM2 | 1.48e-05 | 196 | 210 | 10 | 3252_UP |
| Drug | Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.48e-05 | 196 | 210 | 10 | 3416_DN | |
| Drug | 5279552; Down 200; 22uM; MCF7; HT_HG-U133A_EA | DACH1 RNF43 NFATC3 ASPSCR1 ARAP1 GIT1 DUSP8 CAVIN1 MINDY1 RAB11FIP3 | 1.48e-05 | 196 | 210 | 10 | 960_DN |
| Drug | Betamethasone [378-44-9]; Down 200; 10.2uM; PC3; HT_HG-U133A | IL11 ESRRA JUND ASPSCR1 ARAP1 SEMA3F ADGRL1 RELB ARHGEF10 LRP3 | 1.48e-05 | 196 | 210 | 10 | 6728_DN |
| Drug | Lovastatin [75330-75-5]; Up 200; 9.8uM; PC3; HT_HG-U133A | RNF43 SPATA2L PHLDB1 NFATC3 ASPSCR1 DMPK ALK TNS1 IL6 MINDY1 | 1.48e-05 | 196 | 210 | 10 | 6633_UP |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; HL60; HT_HG-U133A | 1.48e-05 | 196 | 210 | 10 | 2388_DN | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | ZYX CIC ZFP36L2 ASPSCR1 ARAP1 TCF3 GIT1 ARHGEF10L CAVIN1 CAPN15 | 1.55e-05 | 197 | 210 | 10 | 4774_DN |
| Drug | Triprolidine hydrochloride [550-70-9]; Down 200; 12.8uM; HL60; HT_HG-U133A | BCL3 GAB2 ZFP36L2 TBC1D22A ALK ARAP1 AMFR GIT1 RASSF7 CAPN15 | 1.55e-05 | 197 | 210 | 10 | 2376_DN |
| Drug | Dapsone [80-08-0]; Down 200; 16.2uM; MCF7; HT_HG-U133A | SETD1A DACH1 CIC PHLDB1 RIN2 ARHGAP17 ADGRL1 FAM53B SRRM2 CEP170B | 1.55e-05 | 197 | 210 | 10 | 1705_DN |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | RNF19B ARAP1 TTC28 GIT1 ADGRL1 RASSF7 SNX1 CAPN15 RAPGEFL1 RAB11FIP3 | 1.55e-05 | 197 | 210 | 10 | 6949_DN |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A | SETD1A ARHGEF17 CIC DMPK ALK ARID3A TAF1C ADGRL1 CAVIN1 SRRM2 | 1.55e-05 | 197 | 210 | 10 | 2766_UP |
| Drug | Mesoridazine besylate [32672-69-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | SETD1A TBC1D2 SOWAHC BAIAP3 ARAP1 GIT1 RELB ARHGEF10 SHARPIN RAB11FIP3 | 1.62e-05 | 198 | 210 | 10 | 7017_UP |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | RNF43 ZFP36L2 MAP3K9 BAIAP3 ARAP1 SEMA3F GIT1 RELB CAPN15 RAPGEFL1 | 1.62e-05 | 198 | 210 | 10 | 3626_DN |
| Drug | Mebendazole [31431-39-7]; Up 200; 13.6uM; HL60; HT_HG-U133A | 1.67e-05 | 158 | 210 | 9 | 2338_UP | |
| Drug | Niflumic acid [4394-00-7]; Down 200; 14.2uM; HL60; HT_HG-U133A | 1.69e-05 | 199 | 210 | 10 | 2399_DN | |
| Drug | Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; MCF7; HT_HG-U133A | ZNF219 CIC SPATA2L JUND TCF3 RASSF7 MICALL1 SHARPIN MINDY1 SNX1 | 1.69e-05 | 199 | 210 | 10 | 3435_DN |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A | ZC3H3 RIN2 BAIAP3 SEMA3F AMFR SZT2 TNS2 FBXO46 DNAAF1 RAB11FIP3 | 1.76e-05 | 200 | 210 | 10 | 4824_DN |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.84e-05 | 169 | 210 | 9 | 5231_DN | |
| Drug | Colchicine [64-86-8]; Up 200; 10uM; HL60; HG-U133A | 3.12e-05 | 171 | 210 | 9 | 1598_UP | |
| Drug | azelastine | 6.30e-05 | 74 | 210 | 6 | CID000002267 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 6.80e-05 | 189 | 210 | 9 | 1643_DN | |
| Drug | CP-319743 [172078-87-4]; Up 200; 10uM; PC3; HT_HG-U133A | 6.80e-05 | 189 | 210 | 9 | 7537_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | PPRC1 BCL3 SOWAHC SPATA2L JUND ZFP36L2 ARHGEF10 CSPG5 RAB11FIP3 | 6.80e-05 | 189 | 210 | 9 | 5203_DN |
| Drug | resveratrol; Down 200; 50uM; MCF7; HG-U133A | 7.08e-05 | 190 | 210 | 9 | 622_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 7.08e-05 | 190 | 210 | 9 | 1056_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 7.68e-05 | 192 | 210 | 9 | 5222_DN | |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; MCF7; HT_HG-U133A | GAB2 PHLDB1 ADGRL1 PWWP3A FAM53B SRRM2 SNX1 CEP170B RAB11FIP3 | 7.68e-05 | 192 | 210 | 9 | 7427_DN |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | ARHGEF17 KCND3 TBC1D22A ALK POU2F2 GUCY1A2 ARHGEF10 CAVIN1 CROCC | 7.68e-05 | 192 | 210 | 9 | 5218_UP |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A | 7.99e-05 | 193 | 210 | 9 | 1647_UP | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.99e-05 | 193 | 210 | 9 | 1644_DN | |
| Drug | felodipine; Down 200; 10uM; MCF7; HT_HG-U133A_EA | ASPSCR1 TCF3 GIT1 ADGRL1 RASSF7 ARHGEF10L PWWP3A CAVIN1 SRRM2 | 7.99e-05 | 193 | 210 | 9 | 965_DN |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 8.31e-05 | 194 | 210 | 9 | 5316_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 8.31e-05 | 194 | 210 | 9 | 7001_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HG-U133A | 8.31e-05 | 194 | 210 | 9 | 428_DN | |
| Drug | Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 8.31e-05 | 194 | 210 | 9 | 4411_DN | |
| Drug | Nilutamide [63612-50-0]; Down 200; 12.6uM; PC3; HT_HG-U133A | BCL3 ZYX JUND PHLDB1 ZFP36L2 TBC1D22A ARHGEF10 RAPGEFL1 RAB11FIP3 | 8.31e-05 | 194 | 210 | 9 | 6763_DN |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 8.31e-05 | 194 | 210 | 9 | 1699_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; PC3; HT_HG-U133A | 8.31e-05 | 194 | 210 | 9 | 4455_DN | |
| Drug | Hexestrol [84-16-2]; Down 200; 14.8uM; HL60; HT_HG-U133A | 8.31e-05 | 194 | 210 | 9 | 2515_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 8.31e-05 | 194 | 210 | 9 | 5914_DN | |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; PC3; HT_HG-U133A | 8.31e-05 | 194 | 210 | 9 | 4642_UP | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A | BCL3 ZYX ZFP36L2 TBC1D22A ADGRL1 GAS2L1 CAPN15 RAPGEFL1 RAB11FIP3 | 8.31e-05 | 194 | 210 | 9 | 4242_DN |
| Drug | diclofenac sodium; Down 200; 10uM; MCF7; HG-U133A | 8.64e-05 | 195 | 210 | 9 | 333_DN | |
| Drug | Solanine alpha [20562-02-1]; Down 200; 4.6uM; HL60; HT_HG-U133A | RNF19B ZC3H3 SPATA2L JUND ZFP36L2 NFATC3 TBC1D22A SHARPIN TNS1 | 8.64e-05 | 195 | 210 | 9 | 2152_DN |
| Drug | Fillalbin [4540-25-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 8.64e-05 | 195 | 210 | 9 | 2813_DN | |
| Drug | PF-00539745-00 [351321-33-0]; Down 200; 10uM; PC3; HT_HG-U133A | 8.64e-05 | 195 | 210 | 9 | 5979_DN | |
| Drug | Fendiline hydrochloride [13636-18-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 8.64e-05 | 195 | 210 | 9 | 7188_DN | |
| Drug | Hemicholinium bromide [312-45-8]; Down 200; 7uM; PC3; HT_HG-U133A | JUND PHLDB1 TBC1D22A TBX2 SEMA3F ADGRL1 LRP3 CAPN15 RAPGEFL1 | 8.64e-05 | 195 | 210 | 9 | 6739_DN |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A | 8.64e-05 | 195 | 210 | 9 | 1688_DN | |
| Drug | Nabumetone [42924-53-8]; Down 200; 17.6uM; MCF7; HT_HG-U133A | ESRRA ARHGEF17 JUND PHLDB1 NFKBIE SEMA3F TCF3 TTC28 RAB11FIP3 | 8.64e-05 | 195 | 210 | 9 | 5428_DN |
| Drug | Estropipate [7280-37-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 8.64e-05 | 195 | 210 | 9 | 6808_UP | |
| Drug | Butoconazole nitrate [32872-77-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A | SETD1A SETD1B DACH1 BCOR ZFP36L2 SEMA3F GIT1 RASSF7 RAB11FIP3 | 8.64e-05 | 195 | 210 | 9 | 3288_DN |
| Drug | Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; HL60; HT_HG-U133A | 8.64e-05 | 195 | 210 | 9 | 1273_UP | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 8.64e-05 | 195 | 210 | 9 | 5241_DN | |
| Drug | Thiamphenicol [15318-45-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 8.64e-05 | 195 | 210 | 9 | 1704_DN | |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A | 8.99e-05 | 196 | 210 | 9 | 5288_UP | |
| Drug | Hesperidin [520-26-3]; Down 200; 6.6uM; HL60; HT_HG-U133A | RNF19B KMT2A ARID3A TAF1C DUSP8 INTS5 FAM53B CAPN15 RAB11FIP3 | 8.99e-05 | 196 | 210 | 9 | 1294_DN |
| Drug | 17-AAG; Down 200; 1uM; PC3; HG-U133A | 8.99e-05 | 196 | 210 | 9 | 432_DN | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A | 8.99e-05 | 196 | 210 | 9 | 3255_DN | |
| Drug | Lovastatin [75330-75-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A | ZNF219 SOWAHC ZC3H3 ZFP36L2 TCF3 ARHGEF10L MICALL1 INTS5 CAVIN1 | 8.99e-05 | 196 | 210 | 9 | 4978_DN |
| Drug | Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 8.99e-05 | 196 | 210 | 9 | 1487_DN | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A | 8.99e-05 | 196 | 210 | 9 | 3724_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 8.99e-05 | 196 | 210 | 9 | 3844_DN | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A | SETD1A NFATC3 ASPSCR1 SEMA3F AMFR ADGRL1 FBXO46 CSPG5 CAVIN1 | 8.99e-05 | 196 | 210 | 9 | 1531_DN |
| Drug | Repaglinide [135062-02-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 8.99e-05 | 196 | 210 | 9 | 3558_UP | |
| Drug | 0173570-0000 [211245-44-2]; Down 200; 1uM; PC3; HT_HG-U133A | RNF19B SPATA2L KLHL9 ASPSCR1 SEMA3F RASSF7 PWWP3A CAPN15 RAB11FIP3 | 8.99e-05 | 196 | 210 | 9 | 7391_DN |
| Drug | Alcuronium chloride [15180-03-7]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 8.99e-05 | 196 | 210 | 9 | 7345_UP | |
| Drug | Carisoprodol [78-44-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 8.99e-05 | 196 | 210 | 9 | 3251_DN | |
| Disease | neurodevelopmental disorder with speech impairment and dysmorphic facies (implicated_via_orthology) | 4.90e-05 | 2 | 207 | 2 | DOID:0070417 (implicated_via_orthology) | |
| Disease | stomach carcinoma (is_implicated_in) | 7.14e-05 | 12 | 207 | 3 | DOID:5517 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | PRRG1 HIC1 SCARF2 ESRRA APC2 SIX4 CIC NOP9 NHS KLHDC7A ALK AMFR UTS2R MICALL1 GUCY1A2 CAVIN1 LZTS2 TNS1 IL6 CUX1 | 7.47e-05 | 1074 | 207 | 20 | C0006142 |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 2.15e-04 | 17 | 207 | 3 | DOID:0060307 (is_implicated_in) | |
| Disease | serum homoarginine measurement | 3.55e-04 | 20 | 207 | 3 | EFO_0005421 | |
| Disease | social deprivation, COVID-19 | 4.12e-04 | 21 | 207 | 3 | EFO_0009696, MONDO_0100096 | |
| Disease | Anophthalmia-microphthalmia syndrome | 4.12e-04 | 21 | 207 | 3 | cv:C5680330 | |
| Disease | Colorectal Carcinoma | SALL3 APC2 ADARB2 RNF43 AMER2 ZFP36L2 KCND3 GNAS TCF3 STK32C ARHGEF10L GUCY1A2 LZTS2 CUX1 | 4.71e-04 | 702 | 207 | 14 | C0009402 |
| Disease | Intrahepatic Cholangiocarcinoma | 6.18e-04 | 24 | 207 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 6.18e-04 | 24 | 207 | 3 | C3805278 | |
| Disease | Gilles de la Tourette syndrome (is_implicated_in) | 7.21e-04 | 6 | 207 | 2 | DOID:11119 (is_implicated_in) | |
| Disease | myotonic dystrophy type 1 (implicated_via_orthology) | 7.21e-04 | 6 | 207 | 2 | DOID:11722 (implicated_via_orthology) | |
| Disease | Cholangiocarcinoma | 7.85e-04 | 26 | 207 | 3 | C0206698 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 1.20e-03 | 30 | 207 | 3 | EFO_0000341, EFO_0004351 | |
| Disease | Liver Diseases, Parasitic | 1.71e-03 | 9 | 207 | 2 | C0023897 | |
| Disease | Burkitt Lymphoma | 2.05e-03 | 36 | 207 | 3 | C0006413 | |
| Disease | Pseudohypoaldosteronism, Type I | 2.12e-03 | 10 | 207 | 2 | C0268436 | |
| Disease | Pseudohypoaldosteronism | 2.12e-03 | 10 | 207 | 2 | C0033805 | |
| Disease | Hyperpotassemia and Hypertension, Familial | 2.12e-03 | 10 | 207 | 2 | C2713447 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Recessive | 2.12e-03 | 10 | 207 | 2 | C1449843 | |
| Disease | Pseudohypoaldosteronism, Type II | 2.12e-03 | 10 | 207 | 2 | C1449844 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Dominant | 2.12e-03 | 10 | 207 | 2 | C1449842 | |
| Disease | mean platelet volume | ZBTB38 SETD1B BCOR SSH1 KCNQ1 GNAS ARAP1 SEMA3F SET TTC28 CDC42BPB SHANK3 FAM53B CAVIN1 CUX1 RAB11FIP3 | 2.37e-03 | 1020 | 207 | 16 | EFO_0004584 |
| Disease | Other specified cardiac arrhythmias | 2.58e-03 | 11 | 207 | 2 | C0348626 | |
| Disease | Nodal rhythm disorder | 2.58e-03 | 11 | 207 | 2 | C0264893 | |
| Disease | Ectopic rhythm | 2.58e-03 | 11 | 207 | 2 | C1399226 | |
| Disease | CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder) | 2.58e-03 | 11 | 207 | 2 | C2748542 | |
| Disease | atopic dermatitis (implicated_via_orthology) | 2.58e-03 | 11 | 207 | 2 | DOID:3310 (implicated_via_orthology) | |
| Disease | mean arterial pressure | 2.90e-03 | 499 | 207 | 10 | EFO_0006340 | |
| Disease | Neoplastic Cell Transformation | 3.05e-03 | 139 | 207 | 5 | C0007621 | |
| Disease | response to radiation | 3.47e-03 | 88 | 207 | 4 | GO_0009314 | |
| Disease | Brugada Syndrome 1 | 3.63e-03 | 13 | 207 | 2 | C4551804 | |
| Disease | Neuroblastoma | 4.40e-03 | 47 | 207 | 3 | C0027819 | |
| Disease | African Burkitt's lymphoma | 4.84e-03 | 15 | 207 | 2 | C0343640 | |
| Disease | Burkitt Leukemia | 4.84e-03 | 15 | 207 | 2 | C4721444 | |
| Disease | Sinus Node Dysfunction (disorder) | 4.84e-03 | 15 | 207 | 2 | C0428908 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 5.23e-03 | 50 | 207 | 3 | C0023453 | |
| Disease | Congenital total cataract | 5.51e-03 | 16 | 207 | 2 | C0266539 | |
| Disease | teratocarcinoma-derived growth factor 1 measurement | 5.51e-03 | 16 | 207 | 2 | EFO_0008297 | |
| Disease | ureidopropionic acid measurement | 5.51e-03 | 16 | 207 | 2 | EFO_0010542 | |
| Disease | response to hydrochlorothiazide, systolic blood pressure change measurement | 5.51e-03 | 16 | 207 | 2 | EFO_0005202, EFO_0006944 | |
| Disease | glucose measurement | 5.60e-03 | 380 | 207 | 8 | EFO_0004468 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 5.84e-03 | 52 | 207 | 3 | C0023452 | |
| Disease | corpus callosum posterior volume measurement | 5.84e-03 | 52 | 207 | 3 | EFO_0010298 | |
| Disease | Tactile Amnesia | 6.21e-03 | 17 | 207 | 2 | C0750906 | |
| Disease | Amnestic State | 6.21e-03 | 17 | 207 | 2 | C0750907 | |
| Disease | Dissociative Amnesia | 6.21e-03 | 17 | 207 | 2 | C0236795 | |
| Disease | Hysterical amnesia | 6.21e-03 | 17 | 207 | 2 | C0233750 | |
| Disease | Temporary Amnesia | 6.21e-03 | 17 | 207 | 2 | C0233796 | |
| Disease | Amnesia | 6.21e-03 | 17 | 207 | 2 | C0002622 | |
| Disease | Global Amnesia | 6.21e-03 | 17 | 207 | 2 | C0262497 | |
| Disease | Metastatic melanoma | 6.49e-03 | 54 | 207 | 3 | C0278883 | |
| Disease | matrix metalloproteinase 12 measurement | 6.96e-03 | 18 | 207 | 2 | EFO_0010590 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 6.96e-03 | 18 | 207 | 2 | DOID:0080208 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPTPGEPEAPAQDRT | 246 | Q96PM9 | |
| LPPGPDARSISDPPA | 456 | P84996 | |
| CPAPPGPERSPAARA | 16 | H3BQW9 | |
| RAPAAPDPASVDPPS | 341 | Q8N7J2 | |
| LFAGPPVAPSEPTPD | 466 | Q8NCV1 | |
| EPGAPPDPETPAVRA | 971 | O15013 | |
| IPVTDPDPAAAPPGT | 71 | Q9HCE6 | |
| RAAGSPSPLPAPDPA | 496 | Q9BZE9 | |
| ELSAGPPAEPATEPP | 361 | Q9NZN9 | |
| TPPAPGPPSFEEQLR | 556 | Q6ZTN6 | |
| RPLPGYPDAEAPEPS | 11 | Q6NZI2 | |
| PAIPEATEASGPPSP | 141 | O95196 | |
| AREPGTPEPAPSTPE | 31 | Q9HD36 | |
| LRSGSPAPPEPVDPS | 111 | O94812 | |
| PAPPEPVDPSLGLRA | 116 | O94812 | |
| DQPESRRPGSLPAPP | 416 | P39880 | |
| GAPLPRLPPPTSESA | 326 | Q13202 | |
| GPDLPPATAPVPSTR | 451 | O94910 | |
| PVPAVEPVPAPGADS | 21 | P0DPF5 | |
| RILETSGPPPFPAEP | 171 | Q96M93 | |
| RASAPPPAPSEPPAA | 16 | Q8TF64 | |
| GPVPTPPLPSERAEH | 476 | Q9Y2X7 | |
| AAPAPPPLSQDVPGR | 561 | Q96KQ7 | |
| ELGRFPPEESPPAPS | 241 | P13945 | |
| GPPSLPDPTFLPDAE | 1571 | Q9Y4F5 | |
| EPQPPPIVSSEDRGP | 21 | Q3ZCQ2 | |
| PGDTALLLPPSPRPS | 326 | Q6W2J9 | |
| PPASSGPTLFRPEPI | 46 | Q9UI36 | |
| APARPPDFPESSEIP | 761 | Q9BXF3 | |
| DDVHLPPLPAAPGPR | 46 | Q8TE56 | |
| PPSPPRGAQVEEDPA | 21 | A6NCL7 | |
| SDSPPGRPAPAASPE | 191 | C9JTQ0 | |
| EPAPSLSRPGPAAPV | 131 | Q02833 | |
| RPLLPPTPDSGPEGE | 376 | Q8NBR0 | |
| PTPATPAAPGERNPV | 266 | Q9NS39 | |
| PGPGPRSEAPLPELD | 106 | O75154 | |
| SGPFLPPSALLPDPD | 451 | Q01201 | |
| PPPPPHGAAAELART | 311 | Q16676 | |
| VGLPFEASPESPPPA | 631 | Q96TA1 | |
| EASPESPPPASPDGV | 636 | Q96TA1 | |
| TSQGPAAEPEPPRVP | 216 | O75808 | |
| LRSPPETAPEPAGPE | 1571 | Q96PE2 | |
| QEAARSPGPPSPPSE | 776 | Q6ZVH7 | |
| ESPASALEPEPARPP | 816 | Q96DN6 | |
| PPPDGRSEPAPDSHP | 41 | Q86U38 | |
| PLPAAALSPGAPTPR | 6 | Q460N3 | |
| PALTPEGESRPPPAS | 621 | Q9UK17 | |
| AAPPVASDLGPRPPV | 71 | P51787 | |
| DSSPRGDPESPRPPA | 246 | O00165 | |
| SDPFPGLTPRPVPSL | 176 | Q7Z4F1 | |
| GLREPPVPPATADPF | 536 | Q9BRK4 | |
| SLPAERPGPPTPAAA | 111 | Q7Z434 | |
| ERELPPRPDSPPSAG | 261 | Q14526 | |
| LGEPPPPPRASLSSD | 356 | Q9UQF2 | |
| GPEAEDPAPRLPLPH | 226 | O00221 | |
| GSPDPEVPSRASPPV | 386 | Q86X51 | |
| AAPPPTPLRADGAPS | 66 | P17535 | |
| VSPALETPGPPARAP | 1436 | Q96Q04 | |
| ETPGPPARAPDARPA | 1441 | Q96Q04 | |
| AGTPVPEPLPPSFDD | 351 | Q14153 | |
| PGPPRVSPDPRAELD | 26 | P20809 | |
| GDSPAPARPEDTPPA | 336 | Q6PJ61 | |
| GPDSRPDPDGRLPTP | 301 | P06734 | |
| PDPDGRLPTPSAPLH | 306 | P06734 | |
| ADRGPSPAPAPAASP | 896 | Q8IX07 | |
| PRGLPDPALSTQPAP | 806 | Q14005 | |
| PPAEEPRLEPAGPAC | 581 | Q96MW5 | |
| PPLPPTSPGRDVAQD | 471 | Q8WVB3 | |
| EDPSGDSAPAAPLPP | 66 | P09086 | |
| LESPLPEASSAPPGP | 66 | Q8N5J2 | |
| PPEENPGSPSRESPL | 596 | Q9P2J3 | |
| PLVDGPAPADAPREP | 706 | O75074 | |
| SPSPAALPPAPGTEL | 1116 | Q9UBG0 | |
| QELASPPAGRPTPAP | 291 | Q8N3F8 | |
| SPRLVAPVPPGAAPA | 301 | Q86UY5 | |
| PREESLPPAPPLANG | 2131 | Q9UMN6 | |
| AIPGDPTLPSPPAEA | 561 | Q8IXW0 | |
| FPPPPAADGARAPRS | 141 | Q8N319 | |
| AGPRPRPPTAVDPDA | 1261 | O15230 | |
| EPREEPGSPLSPAPR | 11 | B2RBV5 | |
| AVPPSQEERPGPAPT | 1611 | Q9Y5S2 | |
| PDSEVAPAAPVPTPG | 26 | Q7Z6J2 | |
| PPAAAATPGPPADEL | 41 | Q7Z6J2 | |
| AERGAPVPPPDLQPS | 1056 | Q9UPP2 | |
| SAPTLRVEPPSPPEG | 346 | Q6NV74 | |
| PRATDPPSHLDGPPA | 541 | Q09013 | |
| TPPRQPEPPSLVAGA | 996 | Q9Y3Q4 | |
| TLEPARPPQTPGAPA | 306 | Q9BYG4 | |
| ADSSVPPPGLPLAAP | 521 | P0CG20 | |
| TLPDTAAPPGLPPAA | 981 | Q460N5 | |
| SQADERAGTPPPAPP | 381 | Q5T0Z8 | |
| APEAPPPLGAPTAAR | 406 | P81408 | |
| FQPPTLGPEPAARTP | 91 | O95996 | |
| EGASPEPPPPDALAA | 1316 | Q711Q0 | |
| PGPATSPASPDLDPE | 1491 | Q5TZA2 | |
| PGERPADVSPTSPQP | 796 | P32927 | |
| SESRVPPPSDAPLPF | 111 | Q9BXJ0 | |
| AGAAARPAAPPPQPR | 61 | Q5T8R8 | |
| PDAGPRAAAPPDAPA | 46 | Q14184 | |
| RPLSLDGADSAPPPP | 281 | Q12948 | |
| TGPVPDPARAPDPPA | 541 | Q99501 | |
| VSFPPPRVTLPAGPD | 16 | Q969L2 | |
| EALGSLPPPPAAPRE | 781 | P10253 | |
| AALPTEPGPSPVPAF | 6 | Q9ULV5 | |
| AREAAGPEPPPEAQP | 236 | Q9Y5N1 | |
| DSERAVSADPLPPPP | 36 | Q8N4S9 | |
| PLPASPETPERAAGP | 51 | A6NNE9 | |
| AGAPPAVVARTPPEP | 11 | Q3KQU3 | |
| GPRPAPPQEESPSSE | 76 | Q3KQU3 | |
| PPLPRAADTPGTAPA | 251 | Q6ZN01 | |
| RENGAPFVPPPPALD | 176 | Q96QS3 | |
| AEAPPPPPLGAAREE | 496 | Q8NEP3 | |
| PPPLGAAREEPTPQA | 501 | Q8NEP3 | |
| PSPDLAPAAEPAPGA | 526 | O95466 | |
| AALTEVPSPRPPPGS | 311 | Q5VTJ3 | |
| PLGDPDDVPRPFQPT | 126 | Q9UIH9 | |
| PSRSSPEGPDPPVLT | 1681 | Q03164 | |
| PRRPPGDPSTDPEVL | 226 | Q76NI1 | |
| SVAPAPEPSPGFLPV | 626 | Q76NI1 | |
| APAPASAPPGPSEEL | 276 | Q9Y6C2 | |
| PAPPRPSGPATAEDP | 806 | Q9BXX0 | |
| PAPRPSLDPAAPALG | 141 | Q9BYE0 | |
| PLRAPSPEPAAPRGA | 36 | P20749 | |
| AEPAGDTRAPRPPPA | 136 | Q9BXA9 | |
| APGAAAAPAPRPPEL | 41 | P34925 | |
| TEPPVALAPGPAPTR | 31 | P11474 | |
| DNLPPVDAVPSGPAP | 651 | Q5VV67 | |
| PSRDPGEFPRLPDPN | 951 | P80192 | |
| VLPAAFPAPVPPGED | 21 | P05231 | |
| PEPPADSPPAGPLER | 121 | P0DMQ5 | |
| SPPGPLEPSPAAAAA | 41 | P33402 | |
| VATPGDSAIAPPPRP | 341 | Q9UQC2 | |
| PLGSLTAPPAPEPSA | 276 | Q2TAK8 | |
| RSTPDGPADPPLLPI | 111 | Q5HYW3 | |
| QPRVPPSPDDLPSRG | 386 | Q8IYJ3 | |
| APLRPSARPEAPAPG | 586 | Q9H987 | |
| PSSPGPPDPLREEEF | 2316 | Q5T011 | |
| EPPGSSDPPAPRVLR | 511 | O15211 | |
| SDPSTRDPPGRPEPY | 301 | Q5T2D2 | |
| AAQGPPPEALPAEPA | 71 | Q6ZMZ0 | |
| PTPRPPPSAALLAGA | 576 | Q7Z736 | |
| AAGSAPPPTPRPELA | 81 | Q9BWW7 | |
| DEEPPPLPPRGSPAA | 206 | Q8IUW3 | |
| PSPGPDSPPAELAYR | 246 | Q8IUW3 | |
| PEPPAPTPLLAERHG | 361 | Q9UQ35 | |
| EGPTEPPPAEPRTLN | 381 | Q9BZL4 | |
| PAPAPLAPLEPDSGT | 456 | A5PKW4 | |
| SPREAPGAPRSPEPQ | 756 | Q13275 | |
| PLIPSPFGPPTVDRD | 16 | Q7Z3H4 | |
| EVPAAHTGPPAPPRL | 231 | Q8IYG6 | |
| APGPEEPARAVPAPS | 51 | Q6T4R5 | |
| VPAGPEPPPQSSRAE | 536 | Q68EM7 | |
| DLGSLPAAEPPPAPE | 696 | Q15572 | |
| FVSDGPPERTPSLPP | 51 | O15353 | |
| VGSSLPEASPPAPEP | 36 | P57086 | |
| APPPERAAAASPRPG | 116 | Q1XH10 | |
| PRALPEPAPGPVDAS | 616 | Q68DV7 | |
| DEPLPRPPRGAPHAS | 131 | Q92529 | |
| PAPAPFPLEPGDAAT | 46 | Q9UIU6 | |
| QSASPPEPPEGPRAV | 21 | A0A2R8YCJ5 | |
| PRPPPALGPEETSAS | 16 | Q01105 | |
| PPPEADLPRSPGNLT | 156 | Q9H0F6 | |
| TLDFRNAGIPAPPPP | 1571 | Q9UPS6 | |
| PAGSPELSPPQPLFR | 1656 | Q9UPS6 | |
| EAPGPAPFREAPPAE | 11 | B7ZBB8 | |
| VQPLPRTPAPGPSED | 161 | Q53LP3 | |
| RTPAPGPSEDLELPP | 166 | Q53LP3 | |
| ACPGARAAPEPRDPP | 206 | Q9BRJ9 | |
| PSTDPFPGSPAIPAE | 271 | Q6P9B9 | |
| AAPSPEDPELPDTRP | 1531 | Q9ULL5 | |
| STLPPAGRPSEEPEP | 371 | Q9NWQ8 | |
| ARPAGPTEESPPSAP | 1116 | O15047 | |
| PADPAPPSRDGPASR | 836 | Q8WYL5 | |
| APSALPPPAAGQPRA | 31 | Q86UX6 | |
| SPAAGPPLQPREPLS | 31 | Q9UM73 | |
| ASLQPEPPAPARPSA | 51 | Q9UKV5 | |
| PPAAPPGRARAAPDE | 31 | Q99856 | |
| TEDEGLPAAPPIPPR | 106 | Q96P48 | |
| AEAPLPVPPPTGTAA | 1531 | Q96RK0 | |
| EPSPAAPSPAPRDGA | 536 | Q96M02 | |
| PPGAEEPQAPPASRD | 361 | Q86VR2 | |
| PEAAPGDCTRAPPPS | 401 | Q8WYP3 | |
| ERPPEVDPASAPGLP | 221 | Q96IQ9 | |
| PGPSDPPADHAVRPL | 81 | Q8IXZ2 | |
| EPSVLGPSDEPPRPQ | 116 | Q96SZ4 | |
| ADGPAPVSPLEPSPE | 1021 | Q5TCY1 | |
| LPAPPAQEETFAPGP | 271 | Q96PX8 | |
| SERLPPPFPGLEPES | 11 | Q13596 | |
| QDSAPESGDAPRPPP | 896 | Q9BYB0 | |
| ESGDAPRPPPAATPP | 901 | Q9BYB0 | |
| AVAEPLPSPRAQPPG | 1246 | Q9BYB0 | |
| EPAQPPGERSADPPL | 151 | Q2M3V2 | |
| PSQPGTLPDLSRPPD | 466 | P15923 | |
| DDLDRRGPPPPPTAS | 1076 | O14776 | |
| DPPPAREPPTSPGAA | 326 | Q13207 | |
| VAPEAPGRLSPPAAP | 1221 | Q9P227 | |
| PGRLSPPAAPEERPA | 1226 | Q9P227 | |
| TRDPTPRPPGLPEEA | 721 | Q96GP6 | |
| SPARAPPATETPGPE | 816 | Q96GP6 | |
| GAARPADQETPPAPP | 401 | A6NH21 | |
| LPAEGAPEAPRPSSP | 356 | Q9C0C2 | |
| PEPAPRASLESVPPG | 776 | Q9HBL0 | |
| PFGRPDSLPTVLPAP | 176 | A8MX80 | |
| SPPASSPPRVLELPG | 116 | Q9P1Z0 | |
| PPPPGSRPADLEPDD | 26 | Q12968 | |
| REPVDTGPPAPTVAP | 56 | Q6UX34 | |
| EPGPSVPPLVPARSS | 276 | Q86UU1 | |
| SSPGPSPLALEAPAP | 141 | A0A0U1RQS6 | |
| PEAEPPSPPSGDLRL | 126 | Q8WUA7 | |
| AGPSQSPAPPLPEED | 76 | Q8IY26 | |
| PSLPPPRVVGASPSE | 576 | Q96JG9 | |
| LPAATPDPQTPRPGD | 901 | Q96JG9 | |
| PPPPPDEVFDSSGLS | 131 | O14668 | |
| PESPPASAPIPLFGA | 26 | Q96AY4 | |
| VLAPAAPARPAPEGP | 371 | Q9UKP6 | |
| VNPFRPGDSEPPPAP | 36 | Q15942 | |
| PLPPSAPSPTREGAL | 176 | Q8N1G0 | |
| AAREPAEPPPEAGPR | 256 | O60346 | |
| PEAPPLESAEPLGPA | 301 | P35713 | |
| IPPPPPTAASRDSLG | 71 | O43247 | |
| SSDVPGPPAAEVPPL | 326 | Q8NAP3 | |
| REEVGPALPPAAPPA | 546 | Q53EQ6 | |
| EPSQALGPPEPPEAR | 391 | O75127 | |
| AFLREPPAEPGLEPP | 66 | Q9UHV5 | |
| AEPGPRPALQPSPSI | 396 | Q9BXI6 | |
| RLSDSPVFDAPPSPP | 436 | P47974 | |
| SEASPPPARPLPGEA | 986 | Q96J92 | |
| TEPAAESPGRPPPTA | 521 | Q63HR2 | |
| EPEREATPTPAPAAP | 251 | Q9P2Y4 | |
| PVPVPSPAAPDGSRA | 21 | Q93097 | |
| PGSEESARDPQVPPP | 16 | Q9BYX2 | |
| PAAGPQPPAPLAAAR | 656 | Q5EBL2 | |
| QPSTPVDRPLGPDPS | 1216 | O15069 | |
| PSEPSEPIALRGPPA | 586 | Q5VTT5 | |
| PRESLAPAAPADPGP | 41 | Q7Z6G3 |